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ABSTRACT 
 
The importance of insulin delivery and action is best characterized in Type 2 
Diabetes, a disease that is becoming a pandemic both nationally and globally. 
Obesity is a principal risk factor for Type 2 Diabetes, and adipocyte function 
abnormalities due to adipose hypertrophy and hyperplasia, have been linked to 
obesity. Numerous reports suggest that the intracellular and systemic 
consequences of adipocyte function abnormalities include adipocyte insulin 
resistance, enhanced production of free fatty acids, and production of 
inflammatory mediators. A hallmark of adipocyte insulin sensitivity is the 
stimulation of glucose transporter isoform 4 (GLUT4) trafficking events to 
promote glucose uptake. In the Type 2 diabetic and insulin resistant states the 
mechanism behind insulin-stimulated GLUT4 trafficking is compromised. 
Therefore, understanding the role of factors involved in glucose-uptake in 
adipose tissue is of great importance.  
 
Studies from our laboratory suggest an important role for the unconventional 
myosin, Myo1c, in promoting insulin-mediated glucose uptake in cultured 
adipocytes. Our observations suggest that depletion of Myo1c in cultured 
adipocytes results in a significant reduction in the ability of adipocytes to take up 
glucose following insulin treatment, suggesting Myo1c is required for insulin-
mediated glucose uptake. A plausible mechanism by which Myo1c promotes 
glucose uptake in adipocytes has been suggested by further work from our 
laboratory in which expression of fluorescently-tagged Myo1c in cultured 
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adipocytes induces significant membrane ruffling at the cell periphery, insulin-
independent GLUT4 translocation to the cell periphery, and accumulation of 
GLUT4 in membrane ruffling regions. Taken together Myo1c seems to facilitate 
glucose uptake through remodeling of cortical actin.  
 
In the first part of this thesis I, in collaboration with others, uncovered a possible 
mechanism through which Myo1c regulates adipocyte membrane ruffling. Here 
we identified a novel protein complex in cultured adipocytes, comprising Myo1c 
and the mTOR binding partner, Rictor. Interestingly our studies in cultured 
adipocytes suggest that the Rictor-Myo1c complex is biochemically distinct from 
the Rictor-mTOR complex of mTORC2. Functionally, only depletion of Rictor but 
not Myo1c results in decreased Akt phosphorylation at serine 473, but depletion 
of either Rictor or Myo1c results in compromised cortical actin dynamic events. 
Furthermore we observed that whereas the overexpression of Myo1c in cultured 
adipocytes causes remarkable membrane ruffling, Rictor depletion in cells 
overexpressing Myo1c significantly reduces these ruffling events. Taken together 
our findings suggest that Myo1c, in conjunction with Rictor, modulates cortical 
actin remodeling events in cultured adipocytes. These findings have implications 
for GLUT4 trafficking as GLUT4 has been previously observed to accumulate in 
Myo1c-induced membrane ruffles prior to fusion with the plasma membrane. 
 
During our studies of adipocyte function we noticed that current siRNA 
electroporation methods present numerous limitations. To silence genes more 
effectively we employed a lentivirus-mediated shRNA delivery system, and to 
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standardize this technology in cultured adipocytes we targeted Myo1c and 
MAP4K4. Using this technology we were able to achieve clear advantages over 
siRNA oligonucleotide electroporation techniques in stability and permanence of 
gene silencing. Furthermore we showed that the use of lentiviral vectors in 
cultured adipocytes did not affect insulin signaling or insulin-mediated glucose 
uptake events. Despite our inability to use lentiviral vectors to achieve gene 
silencing in mice we were able to achieve adipose tissue-specific gene silencing 
effects in mice following manipulation of the lentiviral conditional silencing vector, 
and then crossing resulting founders with aP2-Cre mice. Interestingly however, 
only founders from the MAP4K4 conditional shRNA vector, but not founders from 
the Myo1c conditional shRNA vector, showed gene knockdown, possibly due to 
position-effect variegation. Taken together, findings from these studies are 
important because they present an alternative means of achieving gene silencing 
in cultured adipocytes, with numerous advantages not offered by siRNA 
oligonucleotide electroporation methods. Furthermore, the in vivo, adipose 
tissue-specific RNAi studies offer a quick, inexpensive, and less technically 
challenging means of achieving adipose tissue-specific gene ablations relative to 
traditional gene knockout approaches.  
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Chapter I 
 
Introduction - Insulin action, adipose metabolic control and GLUT4 trafficking 
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The importance of insulin  
   The human body requires blood glucose to be maintained between 5 and 6 mM 
[1], and insulin functions through its target tissues and organs (skeletal muscle, 
adipose, and liver) to maintain whole body blood glucose levels within this range. 
To do this insulin must activate complex signal transduction pathways, and the 
details of these pathways may vary depending on the target tissue. For instance 
in skeletal muscle and adipose tissue insulin stimulates glucose uptake as a 
consequence of signals leading to the rapid translocation of GLUT4 glucose 
transporters from an intracellular site to the cell surface [reviewed in 2 and 3]. In 
liver however, insulin promotes the conversion and storage of glucose as 
glycogen through the hepatic glycogen synthesis pathway [4]. The importance of 
insulin delivery and action is best characterized in Diabetes Mellitus. During 
Diabetes Mellitus Type 1 (Type 1 Diabetes) the pancreas is unable to produce 
insulin due to permanent destruction of insulin-producing beta cells [5]. Diabetes 
Mellitus Type 2 (Type 2 Diabetes) on the other hand is not a result of defective 
beta cells, but it is characteristic of rather high levels of blood insulin and glucose 
due to the inability of insulin target tissues to respond appropriately to insulin. 
Insulin resistance is a precursor for Type 2 Diabetes, and in association with 
conditions such as hyperglycemia, obesity, cholesterol abnormalities, and 
hypertension (collectively termed Metabolic syndrome), can also increase the risk 
of cardiovascular disease [6].  
   The incidence of diabetes in the United States (U.S.) is currently at astounding 
levels and continues to rise. According to statistics from the Centers for Disease 
Control (CDC), Diabetes (both type 1 and type 2) is the 6th leading cause of 
 3 
death from disease in the U.S. with almost 10 percent of the U.S. population 
afflicted. Interestingly 90 to 95 percent of all cases of diabetes are type 2 in 
nature [7]. Obesity is a principal risk factor for Type 2 Diabetes and the link 
between obesity and Type 2 Diabetes is reflective in the fact that about 80 
percent of people who develop Type 2 Diabetes are obese (based on Body Mass 
Index (BMI) greater or equal to 30) [8]. Therefore, with one-third of U.S. adults 
being categorized as obese the gravity of Type 2 Diabetes is apparent. The 
etiology of obesity is dependent on several factors, but genetic and 
environmental factors play major roles. It is believed however that energy 
imbalance may be the primary cause of this condition (i.e. consuming more 
calories than expending). As discussed by de Ferranti and Mozaffarian, energy 
imbalance results in the storage of surplus energy in adipocytes, which exhibit 
both hypertrophy and hyperplasia [9]. Adipose hypertrophy and hyperplasia have 
been linked to adipocyte function abnormalities with endoplasmic reticulum (ER) 
and mitochondrial stress being two major abnormalities. According to de Ferranti 
and Mozaffarian the intracellular and systemic consequences of such 
abnormalities include adipocyte insulin resistance, production of adipokines, free 
fatty acids, and inflammatory mediators [reviewed in 9]. 
    
The importance of adipose tissue in metabolic control 
   Adipose tissue is a major endocrine and secretory organ [10, 11] and there is 
growing evidence that it is a critical site for whole-body metabolic regulation from 
two different fronts: metabolic regulation through the action of adipocyte-secreted 
peptide hormones (adipokines) [12] and metabolic regulation through lipid 
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signaling [13]. Identified adipokines to date number in excess of 50 [14]. They 
include classic cytokines (tumor necrosis factor-alpha (TNF-α), interleukin (IL)-
1ß), growth factors (transforming growth factor-beta (TGF-β)) and proteins of the 
alternative complement pathway (adipsin); they also include proteins involved in 
the regulation of blood pressure (angiotensinogen), vascular hemostasis 
(plasminogen activator inhibitor-1 (PAI-1)), lipid metabolism (e.g. retinol binding 
protein, cholesteryl ester transfer protein), glucose homeostasis (e.g. 
adiponectin) and angiogenesis (e.g. vascular endothelial growth factor) [reviewed 
in 15]. A number of these adipokines are secreted from white adipose tissue, 
however some (like leptin and adiponectin) are secreted from both white and 
brown adipose tissue. Whereas leptin and adiponectin are important for 
enhancing insulin sensitivity, TNF-α functions to regulate adipokine expression 
[16], stimulate lipolysis, and decrease triglyceride synthesis [17]. In the obese 
state, the increase in circulating levels of TNF-α and other cytokines like IL1ß 
also suggests that obesity is a disorder characterized by mild inflammation, and 
that inflammation may have a causal role in the development of Type 2 diabetes 
and metabolic syndrome [reviewed in 15]. Numerous studies report extensive 
infiltration of adipose tissue by macrophages during obesity [reviewed in 18], and 
adipokines such as TNF-α, MCP-1 and MIF are reported to play a major role in 
this event. Understanding the activities of downstream targets of these 
adipokines may be helpful in understanding the molecular basis for insulin 
resistance and Type 2 Diabetes.          
   Adipose tissue serves as a principal storage site for lipids so it is not surprising 
that the onset of the metabolic syndrome has also been associated with factors 
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that result in the dysregulation of lipid signaling and lipid metabolism [19, 20]. 
According to Cao et al., research to date proposes two primary ideas on the 
influence of adipose tissue lipid metabolism on metabolic syndrome. From one 
perspective lipid storage in adipose tissue protects other organs from exposure 
to excessive lipids, thus reducing the possibility of lipotoxicity. On the other hand, 
and especially in the obese state, high levels of circulating free fatty acids (FFAs) 
may disrupt the function of peripheral tissues and organs, resulting in muscle 
insulin resistance or hepatic steatosis [20]. This could occur through the 
increased activity of TNF-α, MCP-1 and other cytokines, which enhance lipolysis 
and reduce triglyceride synthesis. Indeed, high MCP-1 and TNF-α levels have 
been observed during obesity, and disruption of both genes in mice on a high fat 
diet results in improved insulin sensitivity [21, 22]. The dysregulation of normal 
adipocyte function results in increased circulating FFAs, which causes 
accumulation of triglycerides, and long-chain fatty acyl-CoA esters in liver and 
muscle, causing disruption of normal metabolic activities of these tissues [23]. 
The identification and characterization of the protein mediators behind events 
discussed above is crucial to understanding the links between obesity, insulin 
resistance and Type 2 Diabetes. Work from our laboratory and others has 
resulted in the identification of some of these proteins. Mitogen Activated Protein 
Kinase Kinase Kinase Kinase 4 (MAP4K4) has been found to facilitate TNF-α 
signaling in a variety of cells [reviewed in 18]. According to Guilherme et al., TNF-
α produced by macrophages within adipose tissue of obese subjects may require 
both the IKKß–NF-κB and the JNK–MAP4K4–AP1 signaling pathways [18]. JNK1 
deletion from macrophages and other hematopoietic cells was observed to 
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protect against high-fat diet-induced insulin resistance, by reducing obesity-
induced inflammation [22]. JNK1 is also required for FFA-mediated induction of 
proinflammatory cytokines in macrophages [22]. Interestingly, JNK and MAP4K4 
have been implicated in the pathway leading to TNF-α-induced insulin resistance 
in muscle. In this circumstance exogenously administered TNF-α in humans 
disrupts insulin action and glucose transport in skeletal muscle through Ser and 
Thr phosphorylation events of IRS proteins [24]. This observation confirms our 
own initial ideas on MAP4K4 [25, 26] and also suggests new possibilities for 
MAP4K4, in mediating inhibitory activities of TNF-α on insulin-action in adipose 
tissue. Depletion of MAP4K4 in 3T3-L1 adipocytes results in enhanced 2-
Deoxyglucose uptake due to increased expression of GLUT4 protein and 
adipogenic transcription factors including Peroxisome Proliferator-Activated 
Acceptor γ (PPARγ) [26]. Peroxisome Proliferator-Activated Receptors (PPARs) 
are nuclear hormone receptor proteins that function as transcription factors to 
regulate gene expression and PPARγ is an essential transcriptional regulator of 
adipogenesis and adipocyte protein expression, including GLUT4. PPARγ has 
also been implicated in mature adipocyte function [27, 28], as well as triglyceride 
synthesis and storage [23]. Various studies have shown that like MAP4K4, TNF-
α also influences PPARγ levels [reviewed in 91], leading to the speculation by 
Guilherme et al that TNF-α signals through MAP4K4 to downregulate PPARγ 
function by inhibiting PPARγ protein translation in adipocytes [18]. These ideas 
form the basis for our more recent work in trying to understand the physiological 
relevance of MAP4K4, using adipose tissue-specific MAP4K4 depleted mice. 
This is discussed further in Chapters III & IV.  
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Insulin signaling in adipose tissue and GLUT4 trafficking 
   Apart from being a critical site for whole-body metabolic regulation, adipose 
tissue is also a site for insulin-mediated glucose disposal in humans and mice. 
Here insulin signaling is initiated following binding of insulin to its receptors on 
the surface of target cells. The insulin receptor is a dimeric receptor tyrosine 
kinase consisting of two α-subunits and two β-subunits, and interaction of insulin 
with its receptor results in receptor autophosphorylation at its β-subunits and 
subsequent tyrosine phosphorylation of Insulin Receptor Substrates (IRS) [29]. 
IRS activation is coupled with activation of phosphatidylinositol-3-kinase (PI3K) 
and activated PI3K phosphorylates membrane phospholipids, with the major 
product being phosphatidylinositol 3,4,5 trisphosphate, PIP3. PIP3 activates 
Protein Kinase B (PKB) (also known as Akt) through the action of PIP3-
dependent kinases (PDK 1 and 2) [reviewed in 30]. Numerous studies have 
shown the importance of Akt activation to GLUT4 translocation from perinuclear 
regions to the plasma membrane, in both adipose and muscle cells [31-33]. This 
suggests a similar mechanism is responsible for insulin-mediated GLUT4 
translocation in muscle. However, whereas GLUT4 translocation precedes 
glucose uptake, the insulin signaling events between Akt activation and GLUT4 
translocation are not well understood and is the subject of intense research 
[discussed in 1]. 
   In adipocytes current hypotheses describe a mechanism for GLUT4 
translocation that involves sorting of GLUT4 into intracellular compartments such 
as GLUT4 Storage Vesicles (GSVs), endosomal recycling compartments (ERCs) 
and the Trans Golgi Network (TGN) in the absence of insulin. Furthermore, there 
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is also a pool of GLUT4 in the sorting endosomes/early endosomes (SE/EE), 
which come from recently endocytosed vesicles that have merged [reviewed in 
1]. Following insulin stimulation there is a dramatic exocytosis of GLUT4 from the 
GSV, ERC and potentially SE/EE compartments to the plasma membrane, 
resulting in GLUT4 fusion events [reviewed 1]. The insulin-mediated fusion of 
GLUT4 vesicles and storage compartments with the plasma membrane has been 
suggested by numerous laboratories to occur in three distinct steps: 1) Vesicle 
tethering, during which small GTPase Rab family of proteins have been 
implicated in tethering GLUT4 vesicles to the appropriate target membrane; 2) 
Vesicle docking, where a stable ternary SNARE complex is formed to enable 
docking of the GLUT4 vesicle onto the target membrane following vesicle 
tethering; and 3) Membrane fusion, where once the GLUT4 vesicle has docked it 
fuses with the target membrane and delivers its contents [reviewed in 1 & 3]. The 
occurrence of these events has been beautifully characterized in primary rat 
adipocytes [34] and 3T3-L1 adipocytes [35-37] using Total Internal Reflection 
Fluorescence (TIRF) Microscopy. Whereas the role of insulin in promoting 
GLUT4 trafficking and fusion events is unequivocal, there has been some debate 
about other mechanisms that may contribute to GLUT4 trafficking in response to 
insulin. Some of these include mechanisms involving the actin cytoskeleton and 
actin-based motor proteins.   
 
The actin cytoskeleton and insulin-mediated GLUT4 trafficking 
   Numerous studies have implicated the actin cytoskeleton in GLUT4 subcellular 
localization and trafficking events. For example, 3T3-L1 adipocytes treated with 
 9 
the actin depolymerizing agent cytochalasin D or the G-actin binding toxins 
latrunculin A and B show a marked impairment in insulin-stimulated GLUT4 
translocation [39, 40]. This observation is not unique to GLUT4 vesicle trafficking, 
as the actin cytoskeleton has been reported in numerous other systems to play 
an important role in intracellular protein transport [reviewed in 40]. Whereas the 
precise contribution of the actin cytoskeleton to GLUT4 translocation events is 
not fully understood, there is a lot of data on the numerous possibilities. In 
primary rat adipocytes and cultured 3T3-L1 adipocytes cortical actin has been 
observed to undergo insulin-stimulated dynamic remodeling events [41, 42]. 
Interestingly, cortical actin remodeling has been associated with exocytotic 
events in numerous cell systems but the molecular players behind cortical actin 
dynamics and their contribution to membrane trafficking is not well understood. 
Cortical actin may serve as tracks for the transport of membrane-bound vesicles 
to their destinations via association with actin-based motors [43]. From another 
perspective cortical actin remodeling events may also function to create force 
necessary to move vesicles [44]. Even though the precise role of actin in vesicle 
trafficking is not clear, it is suspected that in 3T3-L1 adipocytes the actin 
cytoskeleton contributes to the mechanism by which GLUT4 vesicles are 
transported to cell periphery [reviewed in 45]. One observation that supports this 
idea is that GLUT4 has been seen to accumulate in sites of cortical actin 
remodeling in adipocytes [46] and primary myocytes [47], following insulin 
stimulation. This suggests that cortical actin remodeling may function to 
concentrate GLUT4-containing vesicles prior to their fusion with the plasma 
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membrane but the potential players behind this event are only beginning to 
emerge.  
   In mammalian cells Myo1c is a 118 KDa protein consisting of a single globular 
catalytic head domain, an α-helical neck region composed of three to four IQ 
domains, and a highly basic tail region [48, reviewed in 38]. The head or motor 
domain is highly conserved amongst Myosins. It is the catalytic core and contains 
actin and nucleotide binding sequences. The neck domain binds calmodulin and 
is regulated by Ca2+ [91]. Whereas the tail domain is the most divergent domain 
amongst unconventional myosins, the mammalian Myo1c tail has been reported 
to harbor a pleckstrin homology (PH) domain that anchors it to PIP2-rich regions 
of the plasma membrane [45]. Previous studies from our laboratory identified 
Myo1c as an important facilitator of glucose uptake in 3T3-L1 adipocytes [48] by 
concentrating in PIP2-rich regions of the adipocyte plasma membrane [49] and 
regulating cortical actin remodeling events or membrane ruffling, with no 
evidence of increased actin polymerization [46]. The observation of GLUT4 
accumulation in Myo1c-induced membrane ruffles prior to fusion [46] functionally 
ties Myo1c to the translocation and fusion of GLUT4 vesicles with the adipocyte 
plasma membrane. Whereas the specific stage of the membrane fusion event at 
which Myo1c acts is not yet clear our observations correlate nicely with proposed 
contributions of other unconventional myosins during actin remodeling events in 
other cells.  
   Research to date shows that the unconventional class of myosins seems to be 
more diverse in function than their myosin II counterparts, with their roles ranging 
from mediating organelle transport to regulating cortical actin during endocytosis, 
 11 
exocytosis and cell motility [50]. Similar to Myo1c, the class I myosins Myo3p and 
Myo5p in yeast, and MyoC in Dictyostelium consist of a catalytic head domain, a 
neck domain and a tail domain [reviewed in 50]. In yeast the mechanism by 
which Myo3p/5p catalytic activity is triggered has been delineated and involves a 
phosphorylation event at a serine residue in the head domain by members of the 
Ste20p family [51, 52]. This phosphorylation event seems highly important and 
implicates the myosin I head domain in the regulation of actin dynamics. The 
importance of the Myo3p/5p head domain in actin dynamics is emphasized 
further by Lechler et al in their observations whereby the motor activity of 
Myo3p/5p is found to be necessary for cortical actin polymerization [54]. 
Altogether these findings make a compelling case for head domain of yeast class 
I myosins as being the regulation center for dynamic actin events. Even though 
there is no correlating evidence as yet from mammalian myosin I orthologs, 
evidence from yeast suggests that mammalian class I myosins could be 
regulated by factors that interact with their head domains.  
   The neck domain of class I myosins harbors at least one IQ consensus motif 
and it is well established that most mammalian and yeast class I myosins interact 
with calmodulin via their neck domains [50, 54]. The tail domains of class I 
myosins are very diverse, even amongst homologues. For instance the tail 
regions of Myo3p/5p have SH3 domains, which may bind an array of ligands [50].  
Even though no SH3 domain has been identified in mammalian Myo1c tail 
regions, recent work by Hokanson et al has identified a Pleckstrin Homology 
(PH) domain within the tail region of mammalian Myo1c and implicated this 
domain in the interaction of Myo1c with PIP2-rich regions of the plasma 
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membrane [55]. Altogether the emerging picture for Myo1c in mammalian cells 
seems one in which Myo1c is anchored to PIP2-rich regions within the plasma 
membrane via its tail domain. Whereas the anchored Myo1c can interact with 
calmodulin in a manner that may be independent of Ca2+ via its neck domain, the 
head domain binds to actin and upon stimulation, or following association with 
other proteins, may be the site for the activation of the actin-remodeling 
machinery at the cell cortex. Our own observations support such a scenario.    
   Blockage of GLUT4 translocation by the disruption of the actin cytoskeleton 
may also be due to interruption of upstream signaling events. Latrunculin B is 
derived from the marine sponge Latrunculia magnifica and causes disruption of 
actin filaments by sequestering monomeric G-actin. Interestingly, latrunculin B 
treatment of 3T3-L1 adipocytes results in decreased Akt phosphorylation [36]. 
This observation suggests a collapse of the insulin-signaling pathway mediating 
GLUT4 translocation to the plasma membrane, following disruption of the cortical 
actin remodeling machinery. Reports by numerous laboratories have also shown 
that depletion of the mTOR binding partner Rictor in numerous cell lines results 
in a decrease in Akt activation as well as disruption of the cortical actin 
remodeling machinery [57 - 62]. We (Figure 1), and others [63] have shown that 
Rictor is important for insulin-mediated glucose uptake in adipocytes. Since Akt 
activation and cortical actin remodeling are necessary events for GLUT4 
translocation, Rictor may be functioning in two distinct capacities to regulate 
GLUT4 translocation: the insulin signaling pathway that activates Akt, and the 
actin polymerization pathway leading to membrane ruffling. To explore this 
hypothesis we performed experiments to better understand how Rictor functions 
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to promote full Akt activation and cortical actin remodeling by attempting to 
identify novel interacting partners of Rictor. To our surprise, apart from previously 
characterized Rictor interacting partners, we also identified Myo1c as an 
associating partner of Rictor. These results are described and discussed further 
in Chapter II.   
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Chapter II 
 
A Rictor-Myo1c complex participates in cortical actin  
remodeling events in 3T3-L1 adipocytes. 
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Summary 
 
Insulin signaling through phosphatidylinositol 3-kinase (PI 3-kinase) activates the 
protein kinase Akt through phosphorylation of its threonine 308 and serine 473 
residues by the PDK1 protein kinase and the Rictor-mammalian target of 
Rapamycin complex (mTORC2), respectively. Remarkably, we show here that 
the Rictor protein is also present in cultured adipocytes in complexes containing 
Myo1c, a molecular motor that promotes cortical actin remodeling. Interestingly, 
the Rictor-Myo1c complex is biochemically distinct from the previously reported 
mTORC2 and can be immunoprecipitated independently of mTORC2. 
Furthermore, while RNA interference-directed silencing of Rictor results in the 
expected attenuation of Akt phosphorylation at serine 473, depletion of Myo1c is 
without effect. In contrast, loss of either Rictor or Myo1c inhibits phosphorylation 
of the actin filament regulatory protein paxillin at tyrosine 118. Furthermore, 
Myo1c-induced membrane ruffling of 3T3-L1 adipocytes is also compromised 
following Rictor knockdown. Interestingly, neither the mTORC2 inhibitor 
Rapamycin nor the PI 3-kinase inhibitor wortmannin affects paxillin tyrosine 118 
phosphorylation. Taken together, our findings suggest that the Rictor-Myo1c 
complex is distinct from mTORC2 and that Myo1c, in conjunction with Rictor, 
participates in cortical actin remodeling events. 
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Introduction 
   The mammalian Target of Rapamycin (mTOR) is an atypical serine/threonine 
kinase that integrates intracellular and extracellular signals from numerous 
pathways to regulate key cellular processes including metabolism and cell 
growth. The actions of mTOR are mediated through at least two distinct mTOR 
complexes that regulate signaling pathways of receptors such as the insulin 
receptor [59, 67]. In one of these complexes, mTOR acts 
in conjunction with the Regulatory Associated Protein of mTOR (Raptor) to 
regulate cell growth through phosphorylation of the eukaryotic initiation 
factor 4E-binding protein (4EBP) and the translational signaling protein p70 
S6 kinase. A second mTOR complex was more recently found to mediate insulin 
receptor signaling to the serine threonine protein kinase B (PKB)/Akt [reviewed in 
68]. Akt activation precedes and mediates many of the metabolic actions of 
insulin and its full activation is associated with its insulin-dependent 
phosphorylation at Thr308 and Ser473 [reviewed in 69]. Whereas the protein 
3-phosphoinositide-dependent protein kinase-1 (PDK1) had been reported to 
phosphorylate Akt at Thr308 in response to insulin, the protein kinase that 
phosphorylates Akt at Ser473 was for a long time unknown. Surprisingly, this 
protein kinase was identified as mTOR in a complex with Rapamycin 
Insensitive Companion of mTOR (Rictor) [67, 68]. Thus, mTOR functions within 
independent complexes to modulate distinct downstream targets.  
   The existence of two TOR complexes was first reported in S. cerevisiae by 
Loewith et al [70]. According to these authors, in S. cerevisiae TOR Complex 1 
(TORC1) consists of TOR1 or TOR2, KOG1, and LST8 whereas TORC2 
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contains TOR2, AVO1, AVO2, AVO3, and LST8. Other laboratories have also 
reported the existence of two distinct mammalian TOR (mTOR) complexes. In 
mammalian cells the mTOR complex 1 (mTORC1) consists of mTOR, GBL (or 
mLST8) and Raptor and is involved in the regulation of cell size [51]. The mTOR 
complex 2 (mTORC2), however, consists of mTOR, GBL, SIN1 and Rictor (or 
mAvo3) and is involved in the full activation of Akt [57, 58, 60, 61]. Interestingly 
Akt phosphorylates and negatively regulates the Rheb GTPase GAP protein 
TSC2, causing the activation of the mTOR-Raptor complex and modulation of its 
downstream bio-effects [reviewed in 68, 72].  
      Interestingly, another function attributed to mTORC2 is the regulation of actin 
organization [63], particularly in serum re-stimulated conditions [64], but the 
mechanisms behind this have not been defined. Sarbassov et al have shown that 
both Rictor and mTOR knockdown in HeLa cells resulted in disrupted actin 
cytoskeleton arrangement, with actin fibers present in the whole cell, and less 
prominent cortical actin, compared to control cells [73]. Consistently, Jacinto et al 
have also shown that knocking down components of the mTORC2 in NIH 3T3 
cells prevented actin polymerization and cell spreading, particularly in serum re-
stimulated cells [74]. In this study, we report results that provide a novel 
connection between the functions of a component of the mTORC2 and regulation 
of the actin cytoskeleton. We report here that Rictor co-immunoprecipitates with 
the actin-based molecular motor Myosin 1c (Myo1c) in 3T3-L1 adipocytes. 
Remarkably, our studies suggest that the Rictor-Myo1c complex is biochemically 
and functionally distinct from the Rictor-mTOR complex. Furthermore, we report 
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here that the Rictor-Myo1c complex participates in dynamic cortical actin events 
in cultured adipocytes.  
 
Materials and Methods 
Materials and chemicals  
   Mouse anti-Myc (clone 9E10) monoclonal antibody was purchased from 
Neomarkers Inc. Rabbit anti-Rictor polyclonal antibody (BL2181) and rabbit anti-
Raptor polyclonal antibody (BL888) were purchased from Bethyl Laboratories. 
Rhodamine-Phalloidin was purchased from Molecular Probes. Unless otherwise 
mentioned, all other antibodies were purchased from Cell Signaling 
Technologies. Latrunculin B was purchased from BioMol. Wortmannin was 
purchased from Sigma-Aldrich. Rapamycin was purchased from Calbiochem.  
 
DNA constructs  
   The construction of 3xHA-Myo1c (IQ domain + tail domain) has been 
previously described [48]. The myc-Rictor construct (Addgene plasmid 11367) 
was obtained from Addgene and has been described previously [73]. The 3xHA-
Myo1c (motor domain + IQ domain + tail domain) (full), 3xHA-Myo1c (motor 
domain + IQ domain) (MIQ), and 3xHA-Myo1c(tail domain) (T) plasmids were 
constructed by subcloning a Myo1c coding sequence encompassing residues 1 
to 1028 (full), 1 to 759 (MIQ), or 760 to 1028 (T), were amplified by PCR, into the 
HindIII and BamH1 restriction sites of pCMV5-triple HA [75] in frame with three N-
terminal triple HA sequences. The GFP-Myo1c plasmid was constructed by 
subcloning a full length Myo1c coding sequence into the HindIII and BamH1 
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restriction sites of pEGFP-C1 plasmid from Clontech. The constructs were 
sequenced and expression was verified in HEK 293T cells prior to experiments. 
 
Cell Culture, cell treatments, and transfection of 3T3-L1 adipocytes and HEK 
293T cells  
   3T3-L1 murine fibroblasts were cultured and differentiated as described 
previously [76]. Differentiated 3T3-L1 adipocytes were transfected on day 4 post-
differentiation by electroporation with 20nmol siRNA as described previously [33]. 
For adipocyte treatments, cells were serum-starved for 3 hours in Dulbecco 
Modified Eagle Medium (DMEM) + 1% penicillin-streptomycin and then treated 
with the reagents described in figure legends. For latrunculin B treatment 3T3-L1 
adipocytes were incubated without (DMSO) or with 2 µM latrunculin B (in DMSO) 
in DMEM supplemented with 10% Fetal Bovine Serum (GIBCO) + 1% penicillin-
streptomycin (GIBCO) for 3 hours before co-immunoprecipitation experiments. 
HEK 293T cells were cultured in DMEM supplemented with 10% Fetal Bovine 
Serum (GIBCO) + 1% penicillin-streptomycin (GIBCO). For HEK 293T 
transfections, 3x106 cells were plated per 150mm plate the day before 
transfection. The following day the 293T cells were transfected with 10 µg of 
myc-Rictor and 10µg of either one of 3xHA-Myo1c(full), 3xHA-Myo1c(motor+IQ), 
3xHA-Myo1c(IQ+tail), or 3xHA-Myo1c(tail) construct DNA using Lipofectamine 
2000 (Invitrogen). 6 hrs post-transfection medium was changed and 48 hours 
post-transfection coimmunoprecipitation and immunoblot assays were 
performed. 
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siRNA oligos  
   Small interfering RNA (siRNA) duplexes were synthesized and purified by 
Dharmacon Research, Inc. (Lafayette, CO). The following siRNA oligos were 
used in this study: 
 
Myo1c siRNA: 5’–GATCATCTGTGACCTGGTATT-3’ 
Rictor siRNA: 5’-GCGAGCTGATGTAGAATTGTT-3’ 
Scrambled siRNA: 5’-CAGTCGCGTTTGCGACTGG-3’ 
 
MEF Immunoprecipitation assays 
   The Rictor wild type and knock out MEFs were scraped into lysis buffer (20 mM 
Tris base, pH 7.9, 20 mM NaCl, 1 mM EDTA, 5 mM EGTA, 20 mM Beta-
glycerophosphate, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 25nM 
calyculin A, 1 tablet/50 ml protease inhibitor (Roche Molecular Biochemicals) 
containing 0.25% CHAPS.  Lysates were centrifuged at 13,500 rpm for 10 min.  
Aliquots of the supernatants containing equal amounts of protein, measured by 
Bradford assay (Bio-Rad), were added to 15 µl of settled Protein A DynaBead 
(Invitrogen) pre-incubated with normal rabbit IgG or Rictor polyclonal antibody 
and incubated at 4oC for 2 hours. The Rictor antibody was raised against a 
prokaryotic recombinant GST-Rictor (1507-1708) polypeptide, and affinity 
purified by binding to a biotinylated Rictor (1507-1708) expressed in the pinpoint 
vector. Beads were washed three times with 1 ml of lysis buffer, twice with 1 ml 
of lysis buffer containing 0.5 M NaCl, and again with 1 ml of lysis buffer.  The 
beads with adsorbed proteins were added to lysis buffer and SDS sample buffer 
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at 1X and heated at 95oC for 10 min. Samples were separated by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The gel was 
silver-stained and bands were excised and submitted for tryptic digestion and 
mass spectrum analysis.  
 
3T3-L1 adipocyte and 293T Immunoprecipitation assays 
   3T3-L1 murine fibroblasts were grown to confluency in 150mm dishes and 
differentiated as described previously [76]. On day 7 post differentiation the 
adipocytes were serum-starved for 3 hours in Dulbecco Modified Eagle Medium 
(DMEM) + 1% penicillin-streptomycin and either left serum-starved or stimulated 
with 100nM insulin for 15 minutes. HEK 293T fibroblasts were also grown and 
transfected in 150mm dishes. Following treatments or transfections cells were 
rinsed twice with cold PBS and lysed in 1 ml of ice-cold S-50 lysis buffer (50 mM 
HEPES (pH 7.4), 5 mM sodium pyrophosphate, 5 mM ß-glycerophosphate, 10 
mM sodium fluoride, 2 mM EDTA, 2 mM Sodium Orthovanadate (Na3VO4), 1 mM 
phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin,) containing 
either 0.3% CHAPS or 1% Triton X-100. Lysates were centrifuged at 13,000 rpm 
for 10 min. Total protein concentration was measured by Bradford assay (Bio-
Rad). 10ug of each indicated antibody or control IgG was added to 2 mg of total 
protein and incubated overnight at 4°C, followed by incubation with swelled 
protein A- or protein G-Sepharose beads (Sigma) for 2 h at 4°C. The beads with 
captured proteins were washed four times with lysis buffer before boiling for 5 
min in Laemmli buffer. Samples were resolved by SDS-PAGE and proteins 
transferred to Polyvinylidene fluoride (PVDF) membranes for immunoblotting. 
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Immunoblot assays 
   For immunoblots, cells were lysed with indicated detergent and total protein 
concentration was measured as described previously [77]. Unless otherwise 
stated 50 µg of total protein was resolved by SDS-PAGE. Proteins were 
transferred to PVDF membranes and membranes were probed with specific 
monoclonal or polyclonal antibodies overnight at 4°C. Bound primary antibody 
was visualized using horseradish peroxidase-conjugated secondary antibody 
(Vector Laboratories) and enhanced chemiluminescence reagents (Pierce). 
 
Live cell imaging and fixed cell Rhodamine-Phalloidin staining  
   For live cell imaging experiments day 4 3T3-L1 adipocytes were co-transfected 
with 50ug plasmid DNA and 10nM siRNA as described previously [33], and 
seeded in 35-mm-diameter plastic tissue culture dishes with glass coverslip 
bottoms (Mat-Tek) for live cell imaging, 6-well culture plates for fixed cell assay, 
and 100mm culture plates for immunoblot analysis. 72 hours post transfection 
the adipocytes were serum starved for 5 hours. For live cell imaging adipocytes 
were washed three times and incubated in Krebs-Ringer-HEPES (KRH) buffer 
containing 0.5% Bovine Serum Albumin (BSA) and 1 mM sodium pyruvate (KBP 
buffer). Images of fluorescently labeled live adipocytes were obtained using a 
Yokogawa spinning disk confocal scan head (model CSU10; Solamere 
Technology Group, Salt Lake City, UT, USA) illuminated with an argon ion laser 
(Reliant 150M, Laser Physics, West Jordan, UT) set at 488 nm. Images from live 
cells were collected at a frequency of 1 image every 5 seconds for 10 minutes, 
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with exposure time of 100ms. Metamorph Image acquisition and analysis 
software (Universal Imaging) was used to control the hardware, acquire data, 
and process final images.  For fixed cell analysis of membrane ruffles 3T3-L1 
adipocytes were washed three times with PBS and fixed in 4% paraformaldehyde 
in PBS for 20 minutes at room temperature. Cells were then permeabilized with 
PBS containing 0.1% Triton X-100 for 20 min and stained with rhodamine-
phalloidin (Invitrogen) for 30 minutes. Samples were viewed by fluorescence 
microscopy using a Zeiss Axiophot2 fluorescence microscope (Zeiss, New York, 
NY) using Axiovision software.  
 
Cell quantification 
   Following rhodamine-phalloidin staining of adipocytes, slides were analyzed 
using a Zeiss Axiophotfluorescence microscope. Adipocytes were identified by 
the presence of lipid droplets. FITC-positive (positive for GFP empty vector 
(control) or GFP-Myo1c) 3T3-L1 adipocytes were evaluated for the presence of 
membrane ruffles. For percentage of cells showing membrane ruffles, adipocytes 
that were positive for GFP-Myo1c and displayed dense actin staining at the cell 
periphery were scored as positive for membrane ruffles. This number was 
divided by the total number of GFP-Myo1c-positive cells analyzed. Results were 
reported as a percentage of cells showing membrane ruffles. For membrane 
ruffle size analysis, ruffle size per cell size, on GFP-Myo1c-positive adipocytes 
from both scrambled siRNA and Rictor siRNA-transfected cells was measured 
using Axiovision software, and normalized to GFP intensity for each cell 
analyzed. At least 60 cells were analyzed for each experiment, and shown is the 
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average of 3 independent experiments. All results are given as mean ± the 
standard error (S.E.). 
 
Statistical analysis 
   The results of all experiments are expressed as the means ± S.E. of at least 
three separate experiments, unless otherwise stated. Statistical differences were 
determined by analysis of variance (ANOVA) test. P values of < 0.05 were 
considered significant.   
 
 
Results 
Rictor depletion inhibits insulin-regulated 2-deoxyglucose uptake and GLUT4 
translocation in 3T3-L1 adipocytes. 
   To determine whether Rictor is important for insulin-dependent 2-deoxyglucose 
uptake, 3T3-L1 adipocytes were transfected with scrambled siRNA or siRNA directed 
against Rictor. After 72 hours, the transfected adipocytes were serum-starved and 
insulin-stimulated 2-Deoxyglucose (2DOG) uptake was assessed under basal, 1nM and 
100nM insulin conditions. To ensure that Rictor was being appropriately depleted by the 
siRNA treatment, scrambled siRNA- and Rictor siRNA-transfected cells were lysed and 
immunoblotted for Rictor and Akt (control). The immunoblot analysis revealed that 
Rictor levels were depleted in Rictor siRNA-transfected adipocytes by at least 80% 
(Figure 1A). This resulted in a significant decrease in 2DOG uptake at both 1nM and 
100nM concentrations of insulin (Figure 1B).  To further explore the importance of Rictor 
specifically to GLUT4 translocation, 3T3-L1 adipocytes were cotransfected with a myc-
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GLUT4-GFP construct and scrambled siRNA or siRNA directed against Rictor. After 72 
hours, the transfected adipocytes were serum starved and insulin-stimulated GLUT4 
translocation was assessed under basal, 0.1nM and 1.0nM insulin conditions. Again, to 
ensure that Rictor was being appropriately depleted by the siRNA treatment, scrambled 
siRNA- and Rictor siRNA-transfected cells were lysed and immunoblotted for Rictor and 
Akt (control). The immunoblot analysis revealed that Rictor levels were depleted in 
Rictor siRNA-transfected adipocytes by at least 80% (Figure 2A). This resulted in a 
significant decrease in GLUT4 translocation at both 0.1nM and 1nM concentrations of 
insulin (Figure 2B and 2C). These results confirm the importance of Rictor to insulin-
dependent glucose uptake and GLUT4 translocation. 
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Figure 1 - Rictor depletion inhibits insulin-stimulated 2-Deoxyglucose uptake in 3T3-L1 adipocytes.  
(A) Differentiated 3T3-L1 adipocytes were transfected with 20nmol scrambled siRNA or Rictor siRNA. 72 hours 
post-transfection a subset of these cells were lysed in 1% SDS and immunoblots were performed to assess Rictor 
and Akt (loading control) levels.  
(B) Insulin-stimulated 2-Deoxyglucose uptake was assessed 72 hours following Rictor knockdown. Results shown 
are the averages of three separate experiments.  *, p < 0.05. 
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Figure 2 - Rictor depletion inhibits insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes.  
(A) Differentiated 3T3-L1 adipocytes were cotransfected with 20nmol scrambled siRNA or Rictor siRNA and a myc-
GLUT4-GFP construct. 72 hours post-transfection a subset of these cells were lysed in 1% SDS and immunoblots 
were performed to assess Rictor and Akt (loading control) levels. 
 (B) Myc-GLUT4-GFP translocation assay. Adipocytes expressing myc-GLUT4-GFP were stimulated with 0.1nM and 
1.0nM insulin for 30 minutes. The cells were then fixed and stained with primary and secondary antibodies to detect 
Myc. Data are representative of three separate experiments.  
(C) Quantification of cell surface anti-Myc signal (Alexa 594). Sixty cells from each condition were analyzed for GFP 
(FITC) and myc (Rhodamine) signal. The arbitrary unit represents ratio of the cell-surface Myc signal to total GFP 
signal in each cell as described in [77]. Error bars indicate standard error. * p < 0.05. 
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Myo1c is identified as a potential associating partner of Rictor in wild type and 
Rictor deficient MEFs. 
   To fully understand Rictor's role in regulating insulin-mediated glucose uptake 
in 3T3-L1 adipocytes we decided to look for novel binding partners of Rictor as 
this may give insight to how Rictor functions to promote full Akt activation and/or 
cortical actin remodeling. We performed co-immunoprecipitation experiments of 
Rictor from Mouse Embryonic Fibroblasts (MEFs) of wild type mice. To assert the 
specificity of polypeptides from our co-IP experiments, we took advantage of 
Rictor deficient MEFs derived from Rictor-knockout mice and used results from 
Rictor-knockout MEFs as a control [78]. In our co-immunoprecipitation 
experiments the majority of the bands recovered from the wild type and Rictor-
knockout MEFs were essentially identical (Figure 3A). However there were three 
regions on the gel where the polypeptide bands observed in wild type IPs were 
missing in Rictor deficient MEF lysates (Figure 3A and 3B arrows, enhanced in 
3B). Bands in these regions were excised from WT MEF lysate lanes and 
analyzed by tryptic digestion and mass spectrometry. The bands in the region 
near molecular weight marker (MW) 212 were identified to be mTOR and Rictor, 
thus strongly supporting the validity of our approach. The third band near MW 
116 (Figure 3B arrows) was identified as the unconventional myosin Myosin 1c 
(Myo1c) (Figure 3C). The three bands corresponding to mTOR, Rictor and 
Myo1c that appeared in the IP from WT MEFs were absent from the 
corresponding gel segment from the IPs performed from Rictor deficient MEFs 
(Figure 3A and 3B arrows, enhanced in 3B), suggesting that in addition to 
mTOR, Rictor co-immunoprecipitates with the unconventional myosin, Myo1c. 
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Figure 3 - Rictor co-immunoprecipitates with Myo1c.  
 
(A) Identification of Myo1c as an immunoprecipitating partner of Rictor. Lysates from wild type (WT) and Rictor 
deficient MEFs (from Rictor knockout mice) were subjected to control rabbit IgG or Rictor polyclonal antibody 
immunoprecipitation. After electrophoresing samples on SDS-polyacrylamide gels, the gels were silver-stained. 
The bands in the regions shown as solid triangles were excised and identified by MS analysis. The proteins that 
immunoprecipitated with Rictor from WT MEFs, but were absent in samples treated with control rabbit IgG and in 
samples derived from Rictor knockout MEFs, were further analyzed. As shown in the top panel, the upper two 
bands were mTOR (above MW 212) and Rictor (below MW 212).  
 
(B) The highlighted region of the gel in (A) was enhanced for better visualization of a band in the region around 
MW 116. This band was identified as Myo1c.  
 
(C) Quantification of results. Whereas five Myo1c peptides were found following immunoprecipitation of Rictor 
from wild type MEFs, no Myo1c peptides were found following immunoprecipitation of Rictor from Rictor deficient 
MEFs. Other proteins were identified and the number of peptides found following Rictor IP from WT and Rictor 
knockout MEFs are shown. 
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Rictor and Myo1c co-immunoprecipitate under basal and insulin-stimulated 
conditions in 3T3-L1 adipocytes.   
   Myo1c had been previously identified in our laboratory as an important factor in 
potentiating insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes [76, 
78]. To confirm co-immunoprecipitation between endogenous Rictor and Myo1c 
in 3T3-L1 adipocytes, we performed further experiments. We observed that 
Rictor co-immunoprecipitated with Myo1c in 3T3-L1 adipocytes under both basal 
and 100nM insulin-stimulated conditions (Figure 3D). No significant changes in 
amounts of Myo1c that precipitated with Rictor occurred following insulin 
stimulation. Consistently, by immunoprecipitating Myo1c with anti-Myo1c, we 
were also able to precipitate Rictor, confirming the existence of an endogenous 
Rictor-Myo1c complex in 3T3-L1 adipocytes. Under lysing conditions containing 
0.3% CHAPS, Rictor but not Myo1c was also observed to co-immunoprecipitate 
with mTOR, but neither Rictor nor Myo1c was observed to co-immunoprecipitate 
with Raptor (Figure 3D).  
   The Rictor-mTOR complex has been previously reported to be sensitive to 
detergent and disrupted by 1% Triton-X100 [73]. Therefore, we determined 
whether the Rictor-Myo1c complex was also sensitive to detergent by 
immunoprecipitating Rictor or Myo1c from 3T3-L1 adipocyte lysates prepared 
with 1% Triton-X100. Consistent with the previously published results [73], 
mTOR did not co-precipitate with Rictor from lysates prepared in 1% TritonX-100 
(Figure 3E). 
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Figure 3 - Rictor co-immunoprecipitates with Myo1c (continued)  
 
(D) Co-immunoprecipitation between endogenous Myo1c and Rictor in 3T3-L1 adipocytes subjected to 
0.3% CHAPS lysis conditions. Differentiated 3T3-L1 adipocytes were serum-starved or stimulated with 
100nM insulin for 15 minutes and then lysed with 0.3% CHAPS lysis buffer. Coimmunoprecipitation 
studies were then performed using the 0.3% CHAPS 3T3-L1 adipocyte lysates and antibodies to 
mTOR, Rictor, Myo1c and non-immune rabbit IgG (pull down). Membranes were then blotted for 
mTOR, Rictor, Myo1c and Raptor.  
 
(E) Co-immunoprecipitation between endogenous Myo1c and Rictor in 3T3-L1 adipocytes under 1% 
TritonX-100 lysis conditions. Differentiated 3T3-L1 adipocytes were serum-starved or stimulated with 
100nM insulin for 15 minutes and then lysed with 1% TritonX-100 lysis buffer. Coimmunoprecipitation 
studies were then performed using the 1% TritonX-100 3T3-L1 adipocyte lysates and antibodies to 
mTOR, Rictor, Myo1c and non-immune rabbit IgG (pull down). Membranes were then blotted for 
mTOR, Rictor, Myo1c and Raptor. The results shown are representative of 3 independent experiments. 
In all 3T3-L1 adipocyte coimmunoprecipitation experiments 50µg of total protein was used for lysate 
blots and 2mg of total protein was used for IP experiments. MEF, mouse embryonic fibroblasts; IgG, 
Immunoglobulin G; SDS, Sodium dodecyl sulfate; MS, mass spectrometry; MW, molecular weight; IP, 
immunoprecipitation; WT, wild type MEFS; KO, Rictor knockout MEFs; -, basal conditions; +, 100nM 
insulin stimulation; CHAPS, 3[(3-Cholamidopropyl) dimethylammonio]-propanesulfonic acid. 
 
 
 
 
 32 
In contrast, the Rictor-Myo1c complex was maintained under these conditions, 
and no apparent difference was observed when cells were treated with or without 
insulin (Figure 3E). Furthermore, under these lysing conditions neither Rictor nor 
Myo1c co-immunoprecipitated with mTOR or Raptor (Figure 3E). All together 
these results confirm that there are endogenous complexes containing Rictor and 
significant amounts of Myo1c in 3T3-L1 adipocytes under both basal and insulin-
stimulated conditions.  
 
The Rictor-Myo1c complex, unlike the Rictor-mTOR complex, is stable through 
chronic Rapamycin treatment of cultured adipocytes. 
    The data presented in Figure 3 suggested that the Rictor-Myo1c complex 
might be biochemically distinct from the Rictor-mTOR complex. To test this idea 
further we determined whether the Rictor-Myo1c complex was sensitive to 
Rapamycin since prolonged Rapamycin treatment of 3T3-L1 adipocytes and 
other cells is known to result in physical and functional disruption of the Rictor-
mTOR complex [59]. Consistent with published results, treatment of 3T3-L1 
adipocytes in cell culture media with 100nM Rapamycin over periods up to 72 
hours significantly decreased phosphorylation of Akt at Ser473 (Figures 4A and 
4B). This correlated with a reduction in Rictor-mTOR interaction, initially visible at 
48 hours following Rapamycin treatment (Figure 4C and 4D). These data 
suggest a disassembly of the mTORC2, which mediates Akt activation at Ser473. 
Interestingly, protracted treatment of 3T3-L1 adipocytes with 100nM Rapamycin 
did not result in a significant disruption of the Rictor-Myo1c complex (Figure 4C 
and 4D), 
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Figure 4 - The Rictor-Myo1c complex is insensitive to chronic Rapamycin treatment.  
 
(A) Effect of prolonged Rapamycin treatment on Akt phosphorylation (serine 473) in 3T3-L1 
adipocytes. Differentiated 3T3-L1 adipocytes were treated with100nM Rapamycin for 0, 1, 24, 48, 
or 72 hours. Adipocytes from each time point were lysed with 0.3% CHAPS lysis buffer and 
lysates were immunoblotted for Akt phosphorylation at serine 473 as well as total Akt. Shown are 
representative blots from 3 independent experiments.  
 
(B) Quantitative assessment of the result in (A) based on densitometry analysis from three 
independent experiments. 
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suggesting that the Rictor-Myo1c complex differs in its sensitivity to Rapamycin 
compared to the Rictor-mTOR complex.  
 
The head domain of Myo1c is the most likely region site for Myo1c’s association 
with Rictor. 
     We next sought to determine the domain of Myo1c responsible for the 
association with Rictor. Myo1c is a class I myosin, consisting of 3 major domains: 
a head domain, a neck domain and a tail domain (Fig. 5A).  The head domain 
has conserved ATP- and actin-binding sites, and this domain has been 
suggested to be important in actin polymerization in other class I myosins [33]. 
The neck domain contains 3 Isoleucine – Glutamine (IQ) binding sites that bind 
calmodulin, and it has been implicated in Ca2+-sensitive membrane binding in 
hair cells [79]. The Myo1c tail domain is rich in basic amino acid residues and 
has been reported to bind to phosphatidylinositol 4,5-bisphosphate-(PIP2)-rich 
regions of the plasma membrane [55]. To determine which domain of Myo1c is 
the most likely site for the association with Rictor we prepared 4 different triple 
influenza hemagglutinin protein (3xHA)-tagged Myo1c constructs: 3xHA-Myo1c 
full-length (motor+IQ+tail), 3xHA-Myo1c(motor+IQ), 3xHA-Myo1c(IQ+tail), and 
3xHA-Myo1c(tail) (Figure 5A). Each construct was cotransfected with a myc-
Rictor (full-length) construct into HEK 293T cells and coimmunoprecipitation 
studies were performed by immunoprecipitating myc-Rictor and immunoblotting 
for HA. In these coimmunoprecipitation studies we observed that only the full-
length Myo1c (3xHA-Myo1c(motor+IQ+tail)) and the Motor+IQ domain (3xHA-
Myo1c(motor+IQ)) Myo1c constructs co-immunoprecipitated with myc-Rictor,  
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Figure 4 - The Rictor-Myo1c complex is insensitive to chronic Rapamycin treatment (continued).  
 
(C) Effect of prolonged Rapamycin treatment on Rictor-mTOR and Rictor-Myo1c complex stability. 
Coimmunoprecipitation studies were performed by immunoprecipitating Rictor and immunoblotting for 
mTOR or Myo1c, using the 0.3% CHAPS 3T3-L1 adipocyte lysates from (A). Shown are representative 
blots from 3 independent experiments.  
 
(D) Quantitative assessment of the result in (C) based on densitometry analysis from three independent 
experiments. In all 3T3-L1 adipocyte coimmunoprecipitation experiments 50µg of total protein was used 
for lysate blots and 2mg of total protein was used for IP experiments. R, Rapamycin treatment; p-Akt, 
phospho Akt (serine 473); IP, immunoprecipitation; IB, immunoblot. * p < 0.05, ** p < 0.01. 
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suggesting that Rictor's association with Myo1c most likely occurred within 
Myo1c's head domain (Figure 5B). Furthermore DMSO treatment alone of 3T3-
L1 adipocytes had no effect on cortical actin (arrow heads in Figure 5C upper 
panel), but latrunculin B treatment of 3T3-L1 adipocytes disrupted the integrity of 
cortical actin (Figure 5C lower panel). However, we observed that actin 
microfilament disruption had no effect on Rictor-Myo1c co-immunoprecipitation 
(Figure 5D), suggesting the Rictor-Myo1c complex is not mediated by intact actin 
filaments.  
 
Myo1c is not required for mTORC2-dependent Akt activation in 3T3-L1 
adipocytes.  
   Since the Rictor-mTOR complex had been previously implicated in the 
phosphorylation of Akt at serine 473, and Rictor also co-immunoprecipitates with 
Myo1c (Figure 3), we tested whether Myo1c is necessary for mTORC2-mediated 
Akt phosphorylation. With increasing doses of insulin, Rictor-knockdown cells 
showed a reduction in the levels of Akt phosphorylation at serine 473 compared 
to control, whereas Myo1c depleted cells did not (Figure 6A and 6B). These 
results suggest that Myo1c is not required for mTORC2-dependent Akt 
activation.  
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Figure 5 - Rictor co-immunoprecipitates with the motor domain of Myo1c.  
 
(A) 3xHA-tagged Myo1c constructs are shown. In addition to a full-length 3xHA-tagged Myo1c construct  
(motor + IQ + tail), a motor + IQ domain, an IQ + tail domain, and a tail domain construct of Myo1c were 
prepared for co-transfection and co-immunoprecipitation experiments with a myc-tagged Rictor 
construct.  
 
(B) Co-immunoprecipitation studies of myc-Rictor and 3xHA-Myo1c constructs. HEK 293T cells were 
co-transfected with myc-Rictor and either 3xHA-Myo1c (full), 3xHA-Myo1c (motor+IQ), 3xHA-Myo1c 
(IQ+tail), or 3xHA-Myo1c (tail) Myo1c construct. 48 hours post-transfection cells were lysed with 1% 
TritonX-100 lysis buffer. Lysates were immunoprecipitated for the myc tag and immunoblotted for the 
HA or myc tags. Non-immune rabbit IgG was used as a control for immunoprecipitation. Shown is a 
representative blot from 3 independent experiments. 
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Figure 5 - Rictor co-immunoprecipitates with the motor domain of Myo1c (continued).  
(C) Assessment of latrunculin B effect on cortical actin integrity. 3T3-L1 adipocytes were incubated without or with 2µM 
latrunculin B. 3 hours post-incubation cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% TritonX-100, 
and stained with Rhodamine Phalloidin for cortical actin analysis. Shown are representative frames of cells for each 
condition. Bars 10 µm.  
(D) Co-immunoprecipitation studies of endogenous Rictor and Myo1c following latrunculin B treatment. 3T3-L1 adipocytes 
were incubated without (-) or with (+) 2µM latrunculin B. 3 hours post-incubation cells were lysed with 0.1% TritonX-100 
lysis buffer. Lysates were immunoprecipitated for Rictor and immunoblotted for Myo1c. Non-immune rabbit IgG was used 
as a control for immunoprecipitation. Shown is a representative blot from 3 independent experiments. 3xHA, Triple 
hemagglutin epitope tag; Myc, myc epitope tag; IQ, Isoleucine-Glutamine domain; HEK, Human embryonic kidney cells; 
Lat.B, Latrunculin B. 
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Figure 6 - Rictor depletion but not Myo1c depletion results in decreased Akt (serine 473) 
phosphorylation.  
(A) siRNA-mediated Rictor and Myo1c silencing. Differentiated 3T3-L1 adipocytes were 
transfected with 20nmol of either scrambled siRNAs (S), siRNAs to Rictor (R) or siRNAs to 
Myo1c (M). 72 hours post-transfection the adipocytes were serum starved for 3 hours and then 
left serum starved (0.0nM Insulin), stimulated with 0.1nM insulin, 1nM, 10nM Insulin, or 100nM 
Insulin for 15 minutes. Lysates from each condition were analyzed by immunoblotting to 
determine level of Rictor depletion, level of Myo1c depletion, Akt phosphorylation levels (serine 
473), or total Akt levels. Shown are representative immunoblots from 3 independent experiments. 
(B) Quantitative assessment of the results in (A) based on densitometry analysis from three 
independent experiments. S, scrambled siRNA; R, Rictor siRNA; M, Myo1c siRNA; nM, 
nanomoles concentration. Significance levels for comparison of Myo1c siRNA transfected cells to 
Rictor siRNA transfected cells: * p < 0.05, ** p < 0.01, significance levels for comparison of 
scrambled siRNA transfected cells to Rictor siRNA transfected cells; # p < 0.05, ## p < 0.01, 
significance levels for comparison of Myo1c siRNA transfected cells to Rictor siRNA transfected 
cells. 
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Myo1c or Rictor depletion compromises paxillin phosphorylation at tyrosine 118 
   Previous work has shown that Rictor and the mTORC2 can also regulate actin 
organization [73, 74]. Interestingly, data from our laboratory suggests that Myo1c 
overexpression in 3T3-L1 adipocytes induces insulin-independent cortical actin 
remodeling [46]. We therefore hypothesized that the Rictor-Myo1c complex may 
function to regulate dynamic cortical actin events. Paxillin is a cytoskeleton-
associated protein, which is phosphorylated at tyrosine 118 during events 
associated with remodeling of the actin cytoskeleton [80] and experiments were 
designed to test the effect of Rictor or Myo1c silencing on paxillin 
phosphorylation at tyrosine 118. We observed a considerable reduction in paxillin 
phosphorylation at tyrosine 118 following either Rictor or Myo1c depletion (Figure 
7A), suggesting that both Rictor and Myo1c are required for optimal regulation of 
dynamic actin polymerization. 
 
Paxillin phosphorylation at tyrosine 118 is not dependent on mTOR or PI3K.  
   Whereas earlier studies in both yeast and mammalian cells suggested that the 
functions of the mTORC2 complex are not compromised by the mTOR inhibitor 
Rapamycin [74], other results [59 and Figure 4 in this paper] imply that protracted 
Rapamycin treatment of cells destabilizes mTORC2 and compromises its ability 
to phosphorylate Akt. Apart from phosphorylating Akt, the mTORC2 complex is 
believed to influence actin organization, although the effect of prolonged 
Rapamycin treatment on actin organization has not been studied. We observed 
that Akt phosphorylation at serine 473 was less pronounced in insulin plus 
Rapamycin-treated adipocytes, relative to adipocytes treated with insulin alone,  
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Figure 7 - Rictor and Myo1c both regulate Paxillin phosphorylation at tyrosine 118 in an mTOR and PI3K-
independent manner.  
(A) Rictor and Myo1c silencing compromise paxillin phosphorylation at tyrosine 118 (Y118). Differentiated 3T3-L1 
adipocytes were transfected with either scrambled siRNAs, siRNAs to Rictor, or siRNAs to Myo1c. 72 hours post-
transfection the adipocytes were lysed in 1% SDS buffer and immunoblots were performed to assess Rictor, 
Myo1c, phospho-paxillin (Y118) and total paxillin levels. Shown are representative blots from 3 independent 
experiments.  
(B) Effect of prolonged Rapamycin treatment on phospho-paxillin levels. Differentiated 3T3-L1 adipocytes were 
either left unstimulated and untreated (-/-), unstimulated but treated with 100nM Rapamycin for 72 hours (-/+), 
stimulated with 100nM insulin for 15 minutes but untreated (+/-), or stimulated with 100nM insulin for 15 minutes 
and treated with 100nM Rapamycin for 72 hours (+/+). In all cases when present, insulin was added for the final 
15 minutes of the experiment. Following stimulation and treatment the adipocytes were lysed in 1% SDS and 
immunoblots were performed to assess phospho-paxillin (Y118), total paxillin, phospho-Akt (S473), and total Akt 
levels. Shown are representative blots from 3 independent experiments.  
(C) Effect of wortmannin treatment on phospho-paxillin levels. Differentiated 3T3-L1 adipocytes were either left 
unstimulated and untreated (-/-), treated with 100nM wortmannin for 30 minutes but unstimulated (-/+), untreated 
but stimulated with 100nM insulin for 15 minutes (+/-), or treated with 100nM wortmannin for 30 minutes and 
stimulated with 100nM insulin for 15 minutes (+/+). Following treatment and stimulation the adipocytes were lysed 
and immunoblots were performed to assess phospho-paxillin (Y118), total paxillin, phospho-Akt (S473), and total 
Akt levels. Shown are representative blots from 3 independent experiments. Ins, 100nM insulin; Rap, 100nM 
Rapamycin; Wort, 100nM wortmannin. 
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indicating that the Rapamycin treatment was effective as expected (Figure 7B). 
In contrast, paxillin phosphorylation at tyrosine 118 was unaffected by prolonged 
treatment of 3T3-L1 adipocytes with 100nM Rapamycin (Figure 7B), suggesting 
that mTOR activity was not necessary for paxillin phosphorylation and actin 
reorganization.     
   Our previous work suggests that Myo1c regulates cortical actin remodeling in a 
PI3K-independent manner [46], and the results presented here (Figure 7A) are 
consistent with a model in which Myo1c in complex with Rictor participates in 
dynamic cortical actin polymerization. Taken together, these observations lead to 
the prediction that paxillin phosphorylation at tyrosine 118 should not be affected 
by inhibition of the PI3K pathway. As expected, Akt phosphorylation at serine 473 
was significantly inhibited in adipocytes treated with insulin plus wortmannin, 
relative to treatment with insulin alone (Figure 7C). As with Rapamycin treated 
cells, paxillin phosphorylation at tyrosine 118 was not affected by treatment of 
3T3-L1 adipocytes with 100nM wortmannin (Figure 7C), suggesting that paxillin 
phosphorylation at tyrosine 118 and dynamic cortical actin events were regulated 
in a PI3K-independent manner. These results show that neither chronic 
Rapamycin treatment nor wortmannin have an effect on paxillin phosphorylation 
at tyrosine 118 and thus suggest that the actions of Myo1c and Rictor on the 
regulation of actin dynamics are likely independent of PI3K and mTOR.   
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Rictor depletion abrogates Myo1c-induced membrane ruffling in 3T3-L1 
adipocytes. 
   The data presented in Figures 3-7 are consistent with a model in which Myo1c 
and Rictor both act in a pathway that results in cortical actin remodeling. We 
have previously observed that overexpression of Myo1c in 3T3-L1 adipocytes 
results in dramatic insulin-independent membrane ruffling [46]. To determine 
whether Rictor is required for Myo1c-induced membrane ruffling, Rictor was 
depleted in adipocytes expressing GFP-Myo1c and these adipocytes were 
analyzed. Immunoblot analysis revealed that Rictor levels were significantly 
depleted in Rictor siRNA-transfected adipocytes (Figure 8A). In live cell imaging 
analysis, GFP-Myo1c/scrambled siRNA-transfected adipocytes showed dramatic 
insulin-independent membrane ruffling, with Myo1c concentrated in the 
membrane ruffling regions (Figure 8B GFP-Myo1c/Scrambled siRNA-transfected 
cells, arrows), as we had previously observed [46]. Strikingly, membrane ruffling 
was significantly subdued in GFP-Myo1c/Rictor siRNA-transfected adipocytes 
(Figure 8B GFP-Myo1c/Rictor siRNA transfected). Adipocytes cotransfected with 
GFP-empty vector and scrambled or Rictor siRNA did not show any significant 
membrane ruffling (Figure 8B GFP empty vector/scrambled or Rictor siRNA).   
     In order to quantitatively assess the effect of Rictor depletion on Myo1c-
induced membrane ruffling, transfected adipocytes were serum-starved prior to 
fixation, then permeabilized and probed with rhodamine-phalloidin. Whereas 
GFP-Myo1c/scrambled siRNA-transfected adipocytes showed distinct and 
extensive membrane ruffles (Figure 9A arrow heads and 9B), the incidence of 
membrane ruffles, 
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Figure 8 - Rictor depletion attenuates Myo1c-induced, insulin-independent, membrane ruffling in 3T3-L1 
adipocytes.  
(A) Rictor knockdown in 3T3-L1 adipocytes cotransfected with GFP-Myo1c and scrambled siRNA or Rictor 
siRNA. Differentiated 3T3-L1 adipocytes were cotransfected with GFP empty vector (GFP-E/V) or GFP-Myo1c, 
and scrambled siRNA or Rictor siRNA. 72 hours post-transfection a subset of these cells were lysed in 1% SDS 
and immunoblots were performed to assess Rictor and Akt (loading control) levels.  
(B) Rictor depletion abrogates Myo1c-induced, insulin-independent, membrane ruffling in 3T3-L1 adipocytes (Live 
cell analysis). Effect of Rictor knockdown on Myo1c-induced, insulin-independent membrane ruffling – Live cell 
assay. Differentiated 3T3-L1 adipocytes were cotransfected with GFP empty vector or GFP-Myo1c, and 
scrambled siRNA or Rictor siRNA. 72 hours post-transfection a subset of these cells were serum starved for 5 
hours and then incubated in a Krebs-Ringer-HEPES (KRH) buffer containing 0.5% Bovine Serum Albumin (BSA) 
and 1 mM sodium pyruvate. Membrane ruffling was observed by live monitoring of the cells for 10 minutes, 
imaging them at 5s intervals. Shown is a bright field image and 3 time frames, each 5 minutes apart for a 
representative GFP empty vector/scrambled siRNA transfected adipocyte, a GFP-Myo1c/scrambled siRNA 
transfected adipocyte, a GFP empty vector/Rictor siRNA transfected adipocyte and a GFP-Myo1c/Rictor siRNA 
transfected adipocyte. Scr – scrambled siRNA, Ric – Rictor siRNA, Min, minutes. Bars 10 µm. 
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in GFP-Myo1c/Rictor siRNA-transfected adipocytes was significantly reduced 
(Figure 9A and 9B). Furthermore, by analyzing membrane ruffles of both GFP-
Myo1c/scrambled siRNA-transfected and GFP-Myo1c/Rictor siRNA-transfected 
adipocytes, membrane ruffle size appeared to be significantly larger for GFP-
Myo1c/scrambled siRNA-transfected adipocytes, compared to GFP-Myo1c/Rictor 
siRNA-transfected adipocytes (Figure 9C). GFP empty vector transfected 
adipocytes showed no significant membrane ruffles (Figure 9A). Together these 
data suggest that Rictor is required for Myo1c-induced, insulin-independent 
membrane ruffling in 3T3-L1 adipocytes. 
 
Discussion 
    The key novel finding reported here is the unexpected coimmunoprecipitation 
of the unconventional myosin Myo1c with Rictor, a previously identified protein in 
the mTORC2 that regulates Akt activation (Figures 3-5). Remarkably, the data 
presented indicate there are at least two biochemically and functionally distinct 
Rictor complexes in 3T3-L1 adipocytes: the Rictor-mTOR complex (mTORC2) 
and the Rictor-Myo1c complex (Figure 10). The Rictor-mTOR complex is 
sensitive to TritonX-100 and long-term treatment of cells with Rapamycin, 
whereas the Rictor-Myo1c complex is not (Figure 4). Functionally, the Rictor-
mTOR complex regulates Akt phosphorylation at Ser473 (Figure 6), while the 
Rictor-Myo1c complex seems to participate in cortical actin remodeling and 
membrane ruffling (Figures 8 and 9).  
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Figure 9 - Rictor depletion abrogates Myo1c-induced, insulin-independent, membrane ruffling in 
3T3-L1 adipocytes (Fixed cell analysis).  
 
(A) Differentiated 3T3-L1 adipocytes were cotransfected with GFP empty vector or GFP-Myo1c and 
scrambled siRNA or Rictor siRNA, and seeded on glass cover slips. 72 hours post-transfection these cells 
were serum starved for 5 hours and fixed with 4% paraformaldehyde, permeabilized with 0.1% TritonX-
100, and stained with Rhodamine Phalloidin for membrane ruffle analysis. Shown are representative 
adipocytes for each condition. Bars 10 µm. 
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Figure 9 - Rictor depletion abrogates Myo1c-induced, insulin-independent, membrane ruffling in 3T3-L1 
adipocytes (Fixed cell analysis) (continued).  
(B) For each condition, percent-ruffling cells was determined by scoring the number of GFP-Myo1c-positive cells 
that had membrane ruffles against the total number of cells counted. At least 60 cells were evaluated in each 
experiment. The averaged data from 3 independent experiments are shown with the standard deviation. ** p < 
0.01.  
(C) Effect of Rictor knockdown on Myo1c-induced, insulin-independent membrane ruffle size. 3T3-L1 adipocytes 
were transfected and prepared as described. For each condition membrane ruffle size was determined by 
measuring the size of discernable membrane ruffles for GFP-Myo1c-positive cells in each condition, divided by 
the total size of the cell, as determined using Axiovision software. For each cell evaluated, its GFP intensity was 
determined and the average ruffle size/total cell size ratio from each condition was normalized to average GFP 
intensity of all evaluated cells from each condition. At least 60 cells were assessed in each experiment. The Box-
and-Whisker plots show (top-down) maximum, third percentile, median, first percentile, and minimum. ** p < 0.01. 
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   In a previous study designed to understand the role of Myo1c in GLUT4 
trafficking and membrane dynamics, we observed that Myo1c overexpression 
induced dramatic cortical actin remodeling (membrane ruffling) in 3T3-L1 
adipocytes, in a serum- and insulin-independent manner [46]. This observation 
suggested that Myo1c might mediate the effect of insulin on membrane ruffling in 
3T3-L1 adipocytes, which is supported by our observation that Myo1c depletion 
in 3T3-L1 adipocytes does indeed attenuate insulin-induced membrane ruffling 
(data not shown). Interestingly, expression of Myo1c in cultured adipocytes 
induces membrane ruffling even in the presence of wortmannin, suggesting that 
Myo1c may be functioning downstream or independent of PI3K in activating 
membrane ruffling. Our studies here suggest that formation and maintenance of 
the Rictor-Myo1c complex is not dependent on insulin, Rapamycin or wortmannin 
(Figures 3, 4 and 6). Therefore, to determine the functional relevance of Rictor’s 
association with Myo1c we performed experiments that focused on a Myo1c-
induced and not insulin, Rapamycin, nor wortmannin-dependent membrane 
ruffling. By using insulin independent, Myo1c-induced membrane ruffling as 
readout for a specific Myo1c-dependent event, we could test whether or not 
Rictor participated in this event. Furthermore, our previous results (Figures 3 to 
7) suggested that the Rictor-mTOR complex is independent of the Rictor-Myo1c 
complex. Thus we eliminated possible contributions of the Rictor-mTOR complex 
(whose activity is dependent on serum and insulin) and observed the role of 
Rictor directly on Myo1c function. The data presented in Figures 8 and 9 clearly 
show that Rictor is required for Myo1c-mediated membrane ruffling. Taken 
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Figure 10 - Working model suggesting Rictor may function in two pathways.  
Our data suggests that Myo1c and Rictor form a complex in 3T3-L1 adipocytes that is 
biochemically and functionally distinct from the Rictor-mTOR complex. While the Rictor-mTOR 
complex (I) that phosphorylates and activates Akt is Rapamycin-sensitive, our data suggests that 
the Rictor-Myo1c complex (II) acts in an insulin, Rapamycin and wortmannin insensitive manner 
to participate in paxillin phosphorylation (p-Paxillin) and dynamic cortical actin events. 
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together, our results suggest that Myo1c overexpression induces insulin-
independent cortical actin remodeling and Rictor depletion attenuates this 
Myo1c-induced event.  
     Tyrosine 118 phosphorylation of the scaffolding protein paxillin is thought to 
be an important signal for cytoskeleton-dependent changes in a cell [80]. Insulin 
is known to induce dramatic 3T3-L1 adipocyte membrane ruffling [45], but we 
find that insulin stimulation does not result in a significant increase in the 
phosphorylation state of paxillin at tyrosine 118 (Figure 7). This observation 
suggests that insulin-induced membrane ruffling in 3T3-L1 adipocytes has no 
effect on the phosphorylation state of paxillin at tyrosine 118, and is consistent 
with previous findings [39]. However, we observed that Rictor or Myo1c depletion 
resulted in significant reduction in paxillin phosphorylation at tyrosine 118 (Figure 
7).  These data indicate that the effects of insulin versus the effects of expression 
of Myo1c are mediated, at least in part, by independent mechanisms leading to 
the induction of membrane ruffling in 3T3-L1 adipocytes. Whereas our result is 
novel, it is consistent with previously published work from our laboratory [81] 
suggesting there may be mechanisms that regulate actin dynamics in adipocytes 
that are distinct from the insulin-dependent pathways. Furthermore, the idea that 
the Rictor-Myo1c complex participates in cortical actin remodeling events that are 
distinct from the events regulated by insulin is supported by our observation that 
neither PI3K inhibition by wortmannin, nor mTOR inhibition by Rapamycin affect 
paxillin phosphorylation at tyrosine 118 in 3T3-L1 adipocytes (Figure 7). Further 
work is required to uncover the underlying mechanisms that regulate actin 
dynamics in response to insulin and Myo1c. 
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   The participation of class I myosins in actin dynamics has been reported for 
yeast class I myosins such as Myo3p and Myo5p, which are activated through a 
phosphorylation event at a serine residue in their head domain by members of 
the Ste20p family [51, 52]. Even though there is no direct evidence of this 
regulation for mammalian myosin I orthologs, it is possible that mammalian class 
I myosins could be regulated by factors that interact with their head domains. Our 
finding that the Myo1c head domain is important for Myo1c association with 
Rictor supports such a hypothesis but further work is required to test this.  
   Finally, a potential mechanism by which Rictor may regulate cortical actin 
remodeling is through activation of small GTPase activity. AVO3, the budding 
yeast ortholog of Rictor, is reported to contain a RasGEFN domain that exists N-
terminal to the catalytic GDP/GTP exchange domain in some guanine nucleotide 
exchange factors for Ras-like small GTPases [82]. This raises the possibility that 
Rictor may activate GTPase signaling [83]. Rho family GTPases play an 
important role in the regulation of cortical actin dynamic events in numerous cell 
types [84] including adipocytes [45] and in NIH 3T3 cells mTORC2 has been 
shown to regulate actin organization through Rho family GTPases [60]. It is thus 
conceivable that Myo1c in complex with Rictor could be part of machinery that 
also leads to the activation of Rho family GTPases in 3T3-L1 adipocytes. Future 
work will be needed to test these hypotheses and to determine the mechanism 
through which Rictor-Myo1c participates in cortical actin dynamics.   
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Chapter III  
Adipose specific shRNA-mediated gene silencing in vivo 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 53 
Summary 
 
Induction of RNA interference in mature 3T3-L1 adipocytes by transfection of 
siRNA oligonucleotides can be inefficient, and presents numerous limitations. 
Here we report the application of a lentivirus-mediated shRNA delivery system in 
3T3-L1 adipocytes. To standardize this technology we targeted Myo1c and 
MAP4K4. We were able to establish stable, long term gene silencing, and we 
observed that lentivirus infection of 3T3-L1 adipocytes did not affect insulin 
signaling or insulin-mediated glucose uptake in 3T3-L1 adipocytes. To extend the 
applications of the lentiviral vector system we attempted to produce adipose-
specific Myo1c or MAP4K4 knockdown mice. Injection of infectious lentiviral 
particles into the perivitelline space of fertilized mouse embryos did not result in 
any founders but manipulation of the lentiviral backbone vector and pronuclear 
injection of the modified vector into fertilized embryos resulted in founders 
positive for the Myo1c and MAP4K4 conditional silencing vectors. By crossing 
resulting founders with aP2-Cre mice we were able to attain mice showing 
adipose-tissue specific knockdown. Interestingly, only founders from the 
MAP4K4, but not Myo1c conditional shRNA vector showed gene knockdown, 
possibly due to position-effect variegation. Nonetheless, we report the 
standardization of a lentivirus-mediated method for silencing genes in 3T3-L1 
adipocytes and the development of technology that offers a means of achieving 
tissue-specific gene silencing in vivo. 
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Introduction 
   Specific knockdown by RNA interference (RNAi) of genes suspected to be 
important in a particular event or process has greatly accelerated the pace of 
discovery of key players in various biological pathways. For instance, through the 
use of RNAi-mediated gene silencing in cultured adipocytes, we have dissected 
the insulin-signaling pathway that leads to the translocation of GLUT4 to the 
plasma membrane [85] and identified some important regulators of insulin-
responsive glucose transport [26, 86, 87]. These fore-mentioned studies have 
relied on the induction of RNAi through the use of small interfering RNA (siRNA) 
strands designed to have complementary nucleotide sequences to the targeted 
RNA strand, thus enabling the siRNA, in association with the RNA-induced 
silencing complex (RISC) to cleave the target messenger RNA (mRNA), and thus 
block translation [reviewed in 88]. Whereas this approach to gene silencing 
serves as a great experimental tool there are a few difficulties, especially in the 
application of RNAi to studies in adipocytes. The physiochemical methods of 
introducing siRNAs into 3T3-L1 adipocytes are inefficient and can be detrimental. 
For example, electroporation is the most widely reported method of introducing 
siRNAs into 3T3-L1 adipocytes. However this approach results in substantial 
adipocyte death, and relatively lower knockdown of some genes compared to 
others. Additionally, the siRNA-mediated gene silencing observed in 3T3-L1 
adipocytes is only transient (72 hours). To overcome these difficulties we 
envisioned the delivery of siRNA-coding short hairpin RNAs (shRNAs) into 3T3-
L1 adipocytes via lentiviral vectors.   
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   Lentiviral vectors offer a powerful tool for exogenous gene transfer and 
expression due to the ability of this family of viruses to stably integrate 
transgenes into the genome of target cells [89]. Furthermore, lentiviruses are 
able to transduce terminally differentiated non-dividing cells, a characteristic that 
makes these viral vectors ideal for use as an exogenous gene delivery system 
during adipocyte studies. For the goals of our study we decided to use two 
related lentiviral vectors, pSico (plasmid for Stable RNA interference, conditional) 
and pSicoR (plasmid for Stable RNA interference, conditional Reverse), both 
developed in the laboratory of Dr Tyler Jacks [66]. The pSico lentiviral vector 
allows for conditional expression of shRNAs through the action of Cre 
recombinase. In the absence of Cre recombinase activity there is no shRNA 
expression due to the presence of a CMV-GFP reporter cassette in between the 
U6 promoter and the shRNA-coding region. In the presence of Cre recombinase 
activity the CMV-GFP reporter cassette is removed, thus enabling the U6 
promoter to come into close proximity with the shRNA coding region, resulting in 
shRNA expression and RNAi. The pSicoR lentiviral vector on the other hand 
allows for constitutive shRNA expression in the absence of Cre recombinase 
activity due to the U6 promoter flanking the shRNA coding region. In the 
presence of Cre recombinase activity the U6 promoter-shRNA coding region, and 
the CMV-GFP reporter cassette are removed, allowing for conditional inactivation 
of shRNA expression [66].  
   With these ideas we cloned shRNA oligonulceotides to our genes of interest 
into the pSico and pSicoR lentiviral vectors and subsequently produced 
infectious lentiviral particles that were used to transduce 3T3-L1 adipocytes and 
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achieve conditional or unconditional silencing of our genes of interest 
respectively. The goal of these studies was not only to characterize this lentiviral 
shRNA delivery system as a means of silencing genes in 3T3-L1 adipocytes, but 
also to develop these vectors as a means of achieving conditional gene silencing 
in vivo. To this end we chose to focus our efforts on silencing expression of the 
unconventional myosin, Myosin 1c, and the serine/threonine protein kinase family 
member Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4). 
Whereas we were able to standardize the procedure for achieving lentivirus-
mediated gene silencing in 3T3-L1 adipocytes, technical constraints precluded 
our ability to achieve the same results in mice. To overcome this limitation we 
modified the pSico vector in order to facilitate the process of creating transgenic 
mice that conditionally expressed our shRNA or interest and thus silenced 
expression of target genes.     
 
Materials and Methods 
Materials  
   Rabbit polyclonal anti-Myo1c antibody was generated as described by Bose et 
al [48]. Rabbit polyclonal anti-MAP4K4 antibody was generated in our laboratory. 
Mouse monoclonal anti-Vti1a antibodies were purchased from BD Biosciences. 
293FT cells, ViraPower lentiviral packaging mix (vectors), Lipofectamine 2000, 
and SuperScript one-step RT-PCR kit were purchased from Invitrogen. 
Polybrene and Trizol were purchased from Sigma. All oligonucleotides were 
purchased from Integrated DNA Technologies (IDT).   
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Generation of Plasmids 
   Lentiviral vector expressing Cre recombinase was generated as described by 
Tiscornia et al [90]. The pSico and pSicoR vectors were generated as described 
by Ventura et al [66]. To generate the truncated pSico vector (pSicoT) used in 
the creation of transgenic mice, the full-length pSico vector containing the 
desired shRNA coding region was digested with XbaI and PvuII and only the 
regions of the original pSico vector containing the U6 promoter, 1st LoxP site, 
CMV-EGFP cassette, 2nd LoxP site, shRNA coding region, and Woodchuck 
hepatitis virus posttranscriptional Regulatory Element (WRE) were maintained.  
Oligonucleotides coding for shRNAs used in these studies were annealed and 
cloned into HpaI-XhoI digested pSico and pSicoR as described by Ventura et al 
[66]. The procedure used to design all shRNAs used in this study are described 
in reference 91. The following sequences were used to design shRNA 
oligonucleotides for this study: 
Scrambled:  TGAAGGTTATGAGGAAGGTCTTCAAGAGAGCCTTCCTCATAACCTTCCTTTTTTC 
Myo1c 1:      TGGCGCTGTCCGTCATTGACTTCAAGAGAGTCAATGACGGACAGCGCCTTTTTTC   
Myo1c 2:      TGGCTGTGTACAGCCGGACATTCAAGAGATGTCCGGCTGTACACAGCCTTTTTTC 
Myo1c 3:      TAGGCGGTGGCTAGTGAAATTTCAAGAGAATTTCACTAGCCACCGCCTTTTTTTC 
Myo1c 6:       TAAGCTTCCAGACAGGGATCTTCAAGAGAATCCCTGTCTGGAAGCTTATTTTTTC 
MAP4K4 1:  TGGCGCTGTCCGTCATTGACTTCAAGAGAGTCAATGACGGACAGCGCCTTTTTTC   
MAP4K4 2:  TGGCTGTGTACAGCCGGACATTCAAGAGATGTCCGGCTGTACACAGCCTTTTTTC 
MAP4K4 3:  TAGGCGGTGGCTAGTGAAATTTCAAGAGAATTTCACTAGCCACCGCCTTTTTTTC 
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Cell Culture and cell treatments.  
   3T3-L1 murine fibroblasts were cultured and differentiated as described 
previously [76]. For adipocyte treatments, cells were serum-starved for 3 hours in 
Dulbecco Modified Eagle Medium (DMEM) + 1% penicillin-streptomycin and then 
treated with the reagents described in figure legends. 293FT cells were cultured 
in DMEM supplemented with 10% Fetal Bovine Serum (GIBCO) + 1% penicillin-
streptomycin (GIBCO). 
 
Lentivirus Generation  
   Infectious lentiviral particles were generated as described in reference 7. 
Briefly, 293FT cells were transfected with 72µg of either pSico or pSicoR vectors 
containing the shRNA-coding cassette of interest, and 216µg of lentiviral 
packaging vector mix, and the resulting supernatant was collected after 72 hours. 
Viral supernatants were then filtered in 0.45µm filters and concentrated by 
ultracentrifugation of viral supernatant for 2 hours at 25,000 revolutions per 
minute (rpm). Resulting viral pellets were resuspended overnight in cell culture 
medium containing 8µg/ml Polybrene. Lentivirus titer was determined prior to 
3T3-L1 adipocyte infections.  
 
Lentivirus titer determination 
   Lentiviral titers were determined based on the expression of GFP in a 293FT 
cell based assay. Briefly, 4x105 293FT cells were plated per well in a 6-well plate 
12 hours prior to titering. Six 10-fold dilution series of lentiviral solution were 
generated (1µl, 0.1µl, 0.01µl, 0.001µl, 0.0001µl, and 0.00001µL of virus/well), 
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and applied to 293FT cells overnight. The next day media was replaced with 
fresh cell culture media. At least 48 hours after infection 293FT cells were 
trypsinized for FACS analysis and the percentage of EGFP positive cells were 
recorded. Titer results were determined based on wells that had between 0.1% 
and 10% of cells expressing EGFP. Unless otherwise stated all experiments 
used concentrated virus stocks containing at least 2 × 108 Infectious Units 
(I.U.)/ml.  
 
3T3-L1 adipocyte infection 
   3T3-L1 adipocytes were infected with lentiviral particles at least 5 days post-
differentiation. 3T3-L1 adipocytes were infected with pSico or pSicoR lentivirus 
by applying the virus to cells at a Multiplicity of Infection (MOI) of 72 unless 
stated otherwise. 12 hours post-infection viral media was replaced with fresh cell 
culture media. 3T3-L1 adipocytes were assayed for EGFP expression and gene 
silencing 5 days post infection, unless otherwise stated.   
 
Immunoblot assays 
   For adipocyte lysate immunoblots, cells were solubilized and total protein 
concentration was measured as described previously [77]. Unless otherwise 
stated 50µg of total protein was resolved by SDS-PAGE. Proteins were 
transferred to PVDF membranes and membranes were probed with specific 
monoclonal or polyclonal antibodies overnight at 4°C. Bound primary antibody 
was visualized using horseradish peroxidase-conjugated secondary antibody 
(Vector Laboratories) and enhanced chemiluminescence reagents (Pierce). For 
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mouse tissue immunoblots, mouse tissue was homogenized in ice-cold lysis 
buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM 
ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton 
X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 µg/ml of 
aprotinin, and 5 µg/ml of leupeptin). Total protein concentration was determined 
as described previously [77]. Unless otherwise stated 50µg of total protein was 
resolved by SDS-PAGE. Proteins were transferred to PVDF membranes and 
membranes were probed with specific monoclonal or polyclonal antibodies 
overnight at 4°C. Bound primary antibody was visualized using horseradish 
peroxidase-conjugated secondary antibody (Vector Laboratories) and enhanced 
chemiluminescence reagents (Pierce). 
 
Generation of truncated pSico-Myo1c and MAP4K4 transgenic mice 
   Transgenic mice expressing pSicoT-Myo1c or MAP4K4 shRNA were made as 
described by Xia et al [92]. Briefly, truncated and linearized pSico-Myo1c or 
MAP4K4 were injected into the pronucleus of fertilized eggs, obtained from 
crossing C57BL/6 and SJL mice. Founders that were positive for either 
transgene were identified by PCR of the tail DNA using the primers 5′-
AGAACGGCATCAAGGTGAAC-3′ (forward) and 5′-GAACTCCAGCAGGACCATGT-
3′ (reverse). Lines of both transgenic mice were maintained by crossing founders 
to C57BL/6 mice. To generate adipose-specific Myo1c or MAP4K4 knockdown 
mice, transgenic lines of either pSicoT-Myo1c or pSicoT-MAP4K4 were crossed 
with aP2-Cre mice. Offspring positive for pSicoT-Myo1c or pSicoT-MAP4K4 and 
aP2-Cre were identified by PCR of the tail DNA using the primers mentioned 
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above in addition to the primers 5′-CCTGTTTTGCACGTTCACCG-3′ (forward) 
and 5′-ATGCTTCTGTCCGTTTGCCG-3′ (reverse) for aP2-Cre.  
 
Northern Blots 
   Northern blots were performed as described by Xia et al [92]. Briefly, total RNA 
was extracted from frozen mouse tissue using TRIzol. 30µg of total RNA was 
fractionated on 15% polyacrylamide gels and transferred onto Hybond TM-N+ 
membrane (Amersham Biosciences, Piscataway, NJ). After UV cross-linking, the 
membrane was probed with 32P-labeled synthetic RNA oligonucleotide 
complementary to the antisense strand of MAP4K4 shRNA. Also, membranes 
were probed with 32P-labeled synthetic DNA oligonucleotide (5′-
ACGAATTTGCGTGTCATCCTTGCG-3′) complementary to mouse U6 RNA. 
 
RT-PCR analysis of mRNA 
   RT-PCR analysis of MAP4K4 mRNA was performed as described by Tang et al 
[26].  
 
 
Statistical analysis 
   The results of all experiments are expressed as the means ± S.E. of at least 
three separate experiments, unless otherwise stated. Statistical differences were 
determined by analysis of variance (ANOVA) test. P values of < 0.05 were 
considered significant.   
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Results 
Lentivirus-mediated delivery of shRNAs and gene silencing in 3T3-L1 adipocytes. 
   In order to establish a more effective and efficient means of silencing genes of 
interest in 3T3-L1 adipocytes we decided to use a lentivirus-mediated shRNA 
delivery system. The lentiviral vectors pSico and pSicoR [66 and Figure 11a] 
were chosen. To establish the conditions necessary for lentivirus-mediated 
shRNA delivery and gene silencing we decided to knockdown Myo1c. Three 
different Myo1c shRNA oligos were designed and cloned into the pSicoR vector 
to test for the most effective in achieving knockdown. As shown in Figure 11b 
there was a high level of transduction efficiency with all oligos. However oligo 3 
achieved about 40% knockdown of Myo1c, which was the most significant 
knockdown of all shRNA oligos used in this study (Figure 11c). Based on these 
results we performed all further Myo1c silencing experiments in 3T3-L1 
adipocytes using shRNA oligo 3.  
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Figure 11 - Lentivirus-mediated shRNA delivery and gene silencing in 3T3-L1 adipocytes. 
  
(A) Schematic diagram of the pSico (top) and pSicoR (bottom) lentiviral vectors used to deliver Myo1c shRNA.  
 
(B) 3T3-L1 adipocytes were infected with empty pSicoR lentivirus (E) or pSicoR lentivirus expressing scrambled 
shRNA (Scr), Myo1c shRNA sequence 1 (M1), Myo1c shRNA sequence 2 (M2), Myo1c shRNA sequence 3 (M3), 
or Myo1c shRNA sequence 6 (M6) at an multiplicity of infection of 6. Three days post-infection adipocytes were 
analyzed for GFP expression by fluorescence microscopy, and  
 
(C) Three days post-infection adipocytes were lysed in 1% SDS and immunoblots were performed to 
assess Myo1c expression levels. Vti1a levels were assessed as a loading control. Shown are 
representative images and blots from 3 independent experiments. E, pSicoR-empty vector; S, scrambled 
shRNA; M1, Myo1c shRNA sequence 1; M2, Myo1c shRNA sequence 2; M3, Myo1c shRNA sequence 3; 
M6, Myo1c shRNA sequence 6. 
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Lentivirus-mediated gene silencing in 3T3-L1 adipocytes is best achieved at an 
MOI of 72. 
   After determining the best shRNA oligo for knocking down Myo1c expression in 
3T3-L1 adipocytes we infected 3T3-L1 adipocytes, at increasing MOIs, with 
pSicoR lentivirus expressing scrambled shRNAs or shRNAs to Myo1c. 
Interestingly, GFP expression was apparent in most cells at an MOI of 6 (Figure 
12a), whereas Myo1c knockdown was not readily apparent until higher viral loads 
(MOI of 72) were used (Figure 12B). Furthermore, even though at an MOI of 144 
there was significantly greater Myo1c knockdown compared to an MOI of 72, 
there was also a significant decrease in the levels of the loading control (Vti1a), 
suggesting that higher MOIs were toxic to cells, or resulted in potential off target 
silencing. At an MOI of 72 we achieved about a 60% knockdown of Myo1c. 
Based on the results of these studies we performed all further 3T3-L1 adipocyte 
gene-silencing experiments with lentivirus at an MOI of 72.  
 
Lentivirus-mediated gene silencing in 3T3-L1 adipocytes persists beyond 3 days 
post-infection. 
   Apart from significant death of 3T3-L1 adipocytes following electroporation with 
siRNA oligos, the gene silencing effect is short lived (72 hours at best) [13]. To 
determine how long lentivirus-mediated gene silencing persisted, we infected 
3T3-L1 adipocytes with pSicoR lentivirus expressing scrambled shRNAs or  
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Figure 12 - Evaluation of viral titers on Myo1c silencing in 3T3-L1 adipocytes.  
 
(A) 3T3-L1 adipocytes were infected with pSicoR lentivirus expressing scrambled or Myo1c shRNA at increasing 
MOIs (6, 36, 72, and 144). Three days post-infection adipocytes were analyzed for GFP expression by 
fluorescence microscopy, and  
 
(B) Three days post-infection adipocytes were lysed in 1% SDS and immunoblots were performed to assess 
Myo1c expression levels. Vti1a levels were assessed as a loading control. Shown are representative images and 
blots from 3 independent experiments. S, scrambled shRNA; M, Myo1c shRNA; MOI, Multiplicity of Infection.   
 
 
 
 66 
shRNAs to Myo1c and observed Myo1c expression in these cells over 5 days. 
Interestingly, GFP expression was apparent in as early as 2 days post-infection 
but Myo1c expression decreased with time, with the best knock down apparent at 
5 days (Figure 13a). To further explore how long lentivirus-mediated gene 
silencing persisted we infected 3T3-L1 adipocytes with pSicoR lentivirus 
expressing scrambled shRNAs or shRNAs to Myo1c. These fibroblasts were 
allowed to reach post-confluency, following which they were induced to 
differentiate into adipocytes. We did not observe any effect of lentivirus-infection 
on the ability of 3T3-L1 fibroblasts to differentiate into adipocytes. GFP 
expression was apparent in infected 3T3-L1 fibroblasts as early as 3 days post-
infection, and also in adipocytes 10 days post-differentiation (21 days post-
infection of 3T3-L1 fibroblasts). Interestingly, whereas Myo1c knockdown was 
barely visible in 3T3-L1 fibroblasts 3 days post-infection, Myo1c was knocked 
down by almost 100% in day 10 adipocytes (21 days post-infection of 3T3-L1 
fibroblasts) (Figure 13B). Taken together our results suggest that lentivirus-
mediated gene silencing persists long beyond 3 days post-infection.      
 
Lentivirus infection does not affect insulin signaling or insulin-stimulated glucose 
uptake in 3T3-L1 adipocytes. 
   After determining that lentivirus-infection does not affect 3T3-L1 adipocyte 
differentiation we wanted to know if it had any adverse effects on insulin action in 
3T3-L1 adipocytes. To this end we looked at the effect of lentivirus infection on 
Akt phosphorylation at serine 473 and insulin-stimulated glucose uptake. For this 
experiment we used 3T3-L1 adipocytes stably expressing pSicoR-scrambled or  
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Figure 13 - Time course evaluation of Lentivirus-mediated Myo1c silencing in 3T3-L1 adipocytes. 
 
(A) 3T3-L1 adipocytes were uninfected or infected with pSicoR lentivirus expressing scrambled or Myo1c 
shRNA at an MOI of 72. At 2, 3, 4, and 5 days post-infection adipocytes were lysed in 1% SDS and 
immunoblots were performed to assess Myo1c and Vti1a expression levels at indicated time points. Vti1a 
levels were assessed as a loading control.   
 
(B) The effect of lentivirus infection on the adipocyte differentiation process was also assessed. 3T3-L1 
adipocytes were infected with lentivirus as described above. At three days post-infection and 21 days post-
infection (10 days post-differentiation) cells were lysed with 1% SDS and immunoblots were performed to 
assess Myo1c expression levels. In (A) and (B) Vti1a levels were assessed as a loading control. Shown are 
representative images and blots from at least 3 independent experiments. U, uninfected; S, scrambled 
shRNA; M, Myo1c shRNA. 
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pSicoR-Myo1c shRNAs. Ten days post-differentiation we treated uninfected 
adipocytes or pSicoR-infected adipocytes with 0nM, 1nM or 100nM insulin and 
performed 2-Deoxyglucose glucose uptake assays. Infection of 3T3-L1 
adipocytes with pSicoR-scrambled or pSicoR-Myo1c lentivirus did not affect Akt 
phosphorylation at serine 473 (Figure 14a). Additionally infection of 3T3-L1 
adipocytes with pSicoR-scrambled lentivirus did not have a significant effect on 
insulin-stimulated glucose uptake, compared to the uninfected cells, whereas 
3T3-L1 adipocytes infected with pSicoR-Myo1c lentivirus did (Figure 14b). 
Whereas the decrease in insulin-stimulated glucose uptake following Myo1c 
knockdown confirms our previous observations [48], the slight decrease we see 
in insulin-stimulated glucose uptake for 3T3-L1 adipocytes infected with pSicoR-
scrambled lentivirus may be a result of GFP expression within the cells, as high 
GFP expression has been reported to have deleterious effects in cells [93]. 
Nonetheless our results suggest that lentivirus infection does not affect insulin 
signaling or insulin-stimulated glucose uptake in 3T3-L1 adipocytes. These 
results are similar to results published by another group [94]. 
 
Conditional lentivirus-mediated knockdown of Myo1c in differentiated 3T3-L1 
adipocytes. 
   One utility of the pSico and pSicoR lentiviral vectors is the potential to achieve 
conditional gene silencing. Whereas this has been previously demonstrated in 
thymocytes [66] we wanted to determine their effectiveness for conditional RNAi 
in adipocytes. 3T3-L1 adipocytes were co-infected with pSico-scrambled, pSico- 
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Figure 14  - Lentivirus-transduction of 3T3-L1 adipocytes does not affect insulin signaling or insulin-
stimulated 2-Deoxyglucose.  
 
(A) Differentiated 3T3-L1 adipocytes previously infected with lentivirus expressing scrambled or Myo1c shRNA (5 
days post-infection) were unstimulated (basal), or stimulated with 1nM or 100nM insulin for 20 minutes. The 
adipocytes were then lysed with 1% SDS and immunoblots were performed to assess Myo1c, phospho-Akt (Ser 
473), total Akt and Vti1a (loading control) levels. Immunoblots are representative of at least 3 separate experiments.   
 
(B) Insulin-stimulated [3H] 2-Deoxyglucose uptake. Twenty minutes after insulin stimulation, 2-Deoxyglucose uptake 
was assessed in uninfected 3T3-L1 adipocytes, or adipocytes infected with pSicoR lentivirus expressing scrambled 
shRNAs or shRNAs to Myo1c. 2-Deoxyglucose uptake result is the averages of three separate experiments.  
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Myo1c, pSicoR-scrambled, or pSicoR-Myo1c and empty lentiviral vector (LV-
empty) or lentiviral vector expressing Cre recombinase (LV-Cre). All pSico and 
pSicoR vectors resulted in high levels of transduction efficiency, as is evident 
from the uniform GFP expression in the cells cotransduced with pSico or pSicoR 
and LV-empty (Figure 15a). Interestingly in adipocytes cotransduced with pSico 
or pSicoR and LV-Cre there was almost a complete loss of GFP signal in all cells 
(Figure 15a), suggesting recombination and excision of the CMV-GFP coding 
regions of the pSico and pSicoR vectors as is demonstrated schematically in 
Figure 11a. In adipocytes transduced with LV-empty we observed a reduction in 
Myo1c expression levels (60% knockdown) only in those adipocytes that were 
also transduced with pSicoR-Myo1c (Figure 15b). However, in adipocytes 
transduced with LV-Cre we observed a reduction in Myo1c expression levels 
(70% knockdown) only in those adipocytes that were also transduced with pSico-
Myo1c (Figure 15b). Together, these results provide evidence for the utility of the 
pSico and pSicoR lentiviral vector in achieving conditional gene silencing in 3T3-
L1 adipocytes.         
 
Molecular modifications to the pSico lentiviral vector to facilitate in vivo RNAi. 
   One objective of our studies was to develop a means of achieving conditional 
gene silencing in mice. Whereas in theory a lentivirus-mediated shRNA delivery 
approach offered much promise, in practice we found the application of this 
method to mouse embryos to be technically challenging. For instance this 
method is labor-intensive and requires special equipment and sophisticated 
manipulation of embryos to facilitate infection. For these reasons we were unable  
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Figure 15 - Conditional Myo1c silencing in 3T3-L1 adipocytes using pSico and pSicoR vectors.  
 
(A) 3T3-L1 adipocytes were uninfected or infected with pSico or pSicoR lentivirus expressing scrambled 
or Myo1c shRNA, and an empty lentiviral vector (LV-Empty), or lentivirus expressing Cre Recombinase 
(LV-Cre) at an MOI of 72. 5 days post-infection adipocytes were analyzed for GFP expression by 
fluorescence microscopy, and  
 
(B) Infected adipocytes were lysed with 1% SDS and immunoblots were performed to assess Myo1c and 
Vti1a levels (loading control). Shown are representative images and blots from at least 3 independent 
experiments. U, uninfected; SS, pSico-scrambled shRNA; SM, pSico-Myo1c shRNA; RS, pSicoR-
scrambled shRNA; RM, pSicoR-Myo1c shRNA. 
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to obtain founder mice positive for the pSico transgene when we used this 
method. To overcome this we modified the pSico vector such that it could be 
used as a DNA vector and thus be injected into the pronucleus of fertilized 
mouse embryos. To do this we cloned shRNAs targeting Myo1c and MAP4K4 
into the pSico vector and digested the pSico-Myo1c/pSico-MAP4K4 vector with 
XbaI and PvuII, leaving only the regions of the original pSico vector containing 
the U6 promoter, 1st LoxP site, CMV-EGFP cassette, 2nd LoxP site, shRNA 
coding region, and Woodchuck hepatitis virus posttranscriptional Regulatory 
Element (WRE). This is illustrated in Figure 16. Because the polyA tail for EGFP 
is in the 3I SIN-LTR, we were able to preclude any possibility of EGFP 
expression in primary tissues, as excessive GFP expression may be detrimental 
to mice. The truncated pSico-Myo1c and pSico-MAP4K4 will be referred to as 
pSicoT-Myo1c and pSicoT-MAP4K4 respectively.  
 
Summary of results from pSicoT-Myo1c and pSicoT-MAP4K4 mouse embryo 
pronuclear injections. 
   Following pronuclear injection of fertilized embryos with pSicoT-Myo1c and 
pSicoT-MAP4K4 the embryos were reimplanted into the oviduct of 
pseudopregnant female recipients. About 21 days after implantation potential 
founder mice were born. Three weeks after birth pSicoT transgene integration 
was assessed by PCR-based tail tissue analysis, using probes to pSicoT. From 
our genotyping studies we noticed that for both pSicoT-Myo1c and pSicoT-
MAP4K4 there was a rather low percentage of founders. At 6 weeks these 
founders were  
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Figure 16 - Schematic representation of modified pSico lentiviral vector (pSicoT).  
 
The full-length pSico lentiviral vector is illustrated (upper illustration). In the presence of Cre Recombinase the 
CMV-EGFP coding region is excised, bringing the U6 promoter in proximity to the shRNA coding region, and thus 
activating shRNA expression. For our purposes the pSico vector containing an shRNA coding cassette was 
digested with XbaI and PvuII, leaving only the regions of the original pSico vector containing the U6 promoter, 1st 
LoxP site, CMV-EGFP cassette, 2nd LoxP site, shRNA coding region, and Woodchuck hepatitis virus 
posttranscriptional Regulatory Element (WRE) (lower illustration). Like the full-length pSico vector, Cre 
Recombinase activity results in excision of the CMV-EGFP coding region, bringing the U6 promoter in proximity to 
the shRNA coding region, and thus activating shRNA expression. 
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crossed with aP2-Cre mice and offspring positive for both the pSicoT and aP2-
Cre transgenes were determined using probes to pSicoT and aP2-Cre 
respectively. From these experiments we noticed for both pSicoT-Myo1c and 
pSicoT-MAP4K4, the transgene was transmitted at a rate sparser than 
Mendelian rates, suggesting mosaicism in the founders. As such we had to breed 
several litters to find the transgene. There were also cases where the pSicoT 
transgene was not transmitted at all (non-germline). These results are 
summarized in Table 1.     
 
No apparent Myo1c knockdown despite presence of pSicoT and aP2-Cre 
transgenes. 
   Once we had identified mice positive for the pSicoT-Myo1c and aP2-cre 
transgenes (Figure 17a) we preceded to determine whether there was any 
Myo1c knockdown in adipose tissue depots. Working with one positive mouse 
(mouse 41), aP2 activity and pScioT recombination was assessed in various 
tissues by PCR-based tissue analysis, and the results of this were compared to a 
control mouse that was positive for only the pSicoT-Myo1c transgene (mouse 
38). As shown in Figure 17b, pSicoT excision was evident in epididymal fat (E.  
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Table 1 - Summary of results from pSicoT-Myo1c and pSicoT-MAP4K4 mouse embryo 
pronuclear injections. 
 
 
 pSicoT-Myo1c pSicoT-MAP4K4 
Number of potential 
founder mice 
screened. 
 
64 
 
72 
Number of mice 
positive for pSicoT 
transgene (founders). 
 
6 
 
3 
Percentage of total 
mice positive for 
pSicoT transgene 
(founders) (%). 
 
9.4 
 
4.2 
Number of founders 
passing on pSicoT 
transgene to 
offspring. 
 
2 
 
2 
Percentage of 
founders passing on 
pSicoT transgene to 
offspring (%). 
 
33.3 
 
66.7 
Yield of rodents positive for 
pSicoT transgene in germline 
(%).  
 
 
3.1 
 
2.8 
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fat), subcutaneous fat (S. fat) and brown fat (B. fat) depots in the mouse positive 
for the pSicoT-Myo1c and aP2-cre transgenes, but not the control mouse. 
Surprisingly, recombination of pSicoT-Myo1c was also apparent in muscle tissue 
of the mouse positive for the pSicoT-Myo1c and aP2-cre transgenes (Figure 
17b), suggesting that the Cre recombinase activity in this particular mouse was 
not restricted to adipose tissue depots. This experiment was repeated in other 
mice positive for the pSicoT-Myo1c and aP2-Cre transgenes and the same result 
was obtained. 
   If pSicoT excision was occurring in tissues other than adipose tissue there was 
a possibility that gene silencing may not be conditional and thus adipose-specific, 
as we had expected. To determine if Myo1c was being knocked down, tissue 
from epididymal fat, subcutaneous fat, and brown fat depots and muscle were 
homogenized and Myo1c protein levels were determined in tissue lysates. 
Interestingly the immunoblot showed no evidence of Myo1c knockdown in any 
tissue (Figure 17c) despite the observed excision of the pSicoT transgene 
(Figure 17b). This observation was true for other mice tested as well. Potential 
reasons for this outcome are explored in the discussion of this chapter.       
 
Adipose tissue-specific knockdown of MAP4K4 in mice. 
   In our efforts to develop this technology for conditionally silencing genes in vivo 
we also prepared and tested shRNA oligos for MAP4K4 (Figure 18a). Using 
MAP4K4 shRNA oligo 1, we made pSicoT-MAP4K4 transgenic mice and crossed 
founders with aP2-Cre mice, to obtain mice positive for both the pSicoT-MAP4K4  
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Figure 17 - No apparent Myo1c silencing in mice expressing pSicoT-Myo1c and aP2-Cre transgenes. 
 
(A) Pups from a cross between pSicoT-Myo1c and aP2-Cre mice were screened for the presence of either 
transgene by PCR analysis of tail genomic DNA. Tail genomic DNA was acquired through proteinase K digestion 
of tail tissue and ethanol precipitation of DNA. Mouse 38 was positive for pSicoT-Myo1c only, whereas mouse 41 
was positive for pSicoT-Myo1c and aP2-Cre.  
 
(B) PCR analysis of genomic DNA from epididymal fat (E. fat), subcutaneous fat (S. fat), brown fat (B. fat) and 
skeletal muscle (muscle) showing Cre recombinase activity and excision of CMV-EGFP in pSicoT-Myo1c in 
mouse 41. Genomic DNA was obtained as described above.  
 
(C) Immunoblot analysis of Myo1c and Akt expression in fat and muscle tissue of mice 38 and 41. Tissue was 
obtained from 10 week old mice and homogenized in 1% SDS/1% TritonX-100 lysis buffer. Immunoblots were 
performed to assess Myo1c and Akt (control) levels following excision of pSicoT-Myo1c transgene. Shown are 
representative images and blots from at least 2 independent experiments. 
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and aP2-Cre transgenes (results summarized in Table 1). Once we had identified 
mice positive for the pSicoT-MAP4K4 and aP2-Cre transgenes by PCR we 
proceeded to determine whether there was any MAP4K4 knockdown in adipose 
tissue depots of F1 mice. Two different mice (labeled M2 and M3 in Figure 18b) 
were found to be positive for both transgenes whereas mouse M1 was found to 
be negative for the aP2-Cre transgene. To confirm the activity of the pSicoT 
transgene in these mice we first determined whether MAP4K4 siRNA was 
expressed in subcutaneous adipose tissue, and whether there was any evidence 
of MAP4K4 siRNA expression in muscle. Interestingly, both mouse M2 and M3 
showed MAP4K4 siRNA expression solely in subcutaneous adipose tissue, with 
no expression in muscle tissue, whereas mouse M1 showed no expression of 
MAP4K4 siRNA in subcutaneous adipose tissue or muscle tissue (Figure 18b). 
To determine if MAP4K4 was being knocked down, subcutaneous adipose tissue 
and muscle tissue from the same mice mentioned above were homogenized and 
MAP4K4 expression levels were determined. In agreement with the northern blot 
data, RT-PCR results showed significant MAP4K4 knockdown in subcutaneous 
adipose tissue but no effect on MAP4K4 levels in muscle tissue (Figure 18c). 
Additionally, there was also significant MAP4K4 knockdown in visceral and 
brown adipose depots in these mice and this observation was true for other mice 
tested as well.    
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Figure 18 - Adipose-specific gene silencing in mice expressing pSicoT-MAP4K4 and aP2-Cre 
transgenes. 
 
(A) MAP4K4 knockdown in cultured adipocytes. 3T3-L1 adipocytes were infected with pSicoR lentivirus 
expressing scrambled shRNA, MAP4K4 shRNA sequence 1 (M4K41), MAP4K4 shRNA sequence 2 (M4K42), 
or MAP4K4 shRNA sequence 3 (M4K43). 5 days post-infection adipocytes were lysed in 1% SDS lysing buffer 
and immunoblots were performed to assess MAP4K4 and Vti1a (control) expression levels.  
 
(B) MAP4K4 siRNA expression in muscle and adipose tissue. Pups from a cross between pSicoT-MAP4K4 and 
aP2-Cre mice were screened for the presence of either transgene by PCR analysis of tail genomic DNA. Mouse 
M1 was positive for pSicoT-MAP4K4 only whereas mice M2 and M3 were positive for pSicoT-MAP4K4 and 
aP2-Cre. Northern blot analysis of subcutaneous adipose tissue and skeletal muscle from these mice was 
performed to assess adipose expression of MAP4K4 siRNA. Total RNA from adipose and muscle tissue from 
mice M1, M2, and M3 was harvested and probed with MAP4K41 shRNA-specific probe. C, control sample 
consisting of MAP4K4 siRNA oligonucleotide.  
 
(C) MAP4K4 mRNA expression in muscle and adipose tissue. Real Time PCR analysis was performed to 
assess MAP4K4 expression levels in mice. All experiments were performed in male mice at 6 weeks of age. 
These results have been observed in female mice, other generations and lines. RT-PCR, reverse transcription 
polymerase chain reaction. 
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Adipose tissue-specific MAP4K4 knockdown results in increased PPARу 
expression. 
   Studies on the role of MAP4K4 in adipocyte function and metabolic regulation 
suggest that MAP4K4 acts on at least two related fronts. For instance in 
adipocytes and potentially in muscle, MAP4K4 acts as a mediator of TNFα to 
downregulate PPARу and GLUT4 expression (Figure 19) [reviewed in 111]. Lipid 
accumulation in tissues not suited for fat storage (muscle and liver) may be a 
major contributor to insulin resistance in these tissues, and improving adipocyte 
PPARу activity would be an important means of enhancing lipid storage (as 
triglycerides) in adipocytes, rather than muscle and liver. Our earlier finding that 
MAP4K4 acts as a negative regulator of adipocyte function was based partly on 
the observation that in cultured adipocytes MAP4K4 depletion resulted in 
increased PPARу expression levels, and protected adipocytes from some of the 
adverse effects of TNFα [26]. To determine if subcutaneous adipose tissue from 
pSicoT-MAP4K4/aP2-Cre mice showed a similar pattern for PPARу expression 
levels following MAP4K4 depletion, we isolated preadipocytes from the 
subcutaneous stroma-vascular fraction of white adipose tissue from pSicoT-
MAP4K4 and pSicoT-MAP4K4/aP2-Cre mice and differentiated them into mature 
adipocytes, following which PPARу 1 and 2 expression levels were determined 
by western blot. Consistent with published results, we noticed a significant 
increase in PPARу 1 and 2 expression levels in adipocytes from pSicoT-
MAP4K4/aP2-Cre mice, relative to pSicoT-MAP4K4 mice, supporting the idea 
that MAP4K4 attenuates PPARу expression (Figures 20a & 20b). 
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Figure 19 - Hypothesis for MAP4K4's role in downregulating glucose uptake in adipocytes. 
Observations from our laboratory suggest that MAP4K4 acts as a negative regulator of glucose 
uptake in adipocytes by downregulating the expression of PPARγ and GLUT4, both necessary for 
proper adipocyte function. We believe that MAP4K4 plays a major role in mediating the effects of 
TNF-α on adipocytes (Figure adapted from Tang et al. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 
2087–2092). 
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Figure 20 - Adipose tissue-specific MAP4K4 knockdown results in increased PPARу expression.   
 
(A) Preadipocytes from subcutaneous adipose tissue of pSicoT-MAP4K4 (shM4K4) and pSicoT-MAP4K4/aP2-
Cre (shM4K4/aP2-Cre) mice were isolated and differentiated into mature adipocytes. PPARу 1 and 2 levels were 
determined in these adipocytes by western blot, with each lane representing an individual mouse. Shown is a 
representative western blot.  
 
(B) Results from western blots performed with cells from 3 to 6 different mice in each group were quantified by 
densitometry, and PPARу 1 and 2 levels are expressed +/- s.e.m. *p<0.05. 
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Adipose tissue-specific MAP4K4 knockdown results in increased adipogenic 
gene expression. 
   Our earlier studies on MAP4K4's role in regulating adipocyte function suggest 
that in addition to regulating PPARу expression MAP4K4 also negatively 
regulates the expression of GLUT4 [26]. To further validate our adipose tissue-
specific MAP4K4 knockdown we determined if subcutaneous adipose tissue from 
pSicoT-MAP4K4/aP2-Cre mice showed a similar pattern of attenuated GLUT4 
expression compared to pSicoT-MAP4K4 control mice. Again, we isolated 
preadipocytes from the subcutaneous stroma-vascular fraction of white adipose 
tissue from pSicoT-MAP4K4 and pSicoT-MAP4K4/aP2-Cre mice and 
differentiated them into mature adipocytes, following which GLUT4, aP2, and 
CEBPα expression levels were determined by RT-PCR. Consistent with 
published results, we noticed a considerable increase in GLUT4 expression 
levels in subcutaneous adipocytes from pSicoT-MAP4K4/aP2-Cre mice, relative 
to pSicoT-MAP4K4 mice (Figure 21). Furthermore, we also observed an increase 
in aP2 and CEBPα expression levels in white adipose tissue from pSicoT-
MAP4K4/aP2-Cre mice, relative to pSicoT-MAP4K4 mice (Figure 21) supporting 
our hypothesis that MAP4K4 acts as a negative regulator of adipogenesis. The 
similarity in our observations, of increased PPARγ and GLUT4 expression levels 
following MAP4K4 depletion, in cultured adipocytes and adipocytes from pSicoT-
MAP4K4/aP2-Cre mice supports the validity of our shRNA-based approach to 
achieving adipose tissue-specific gene silencing. Continued work in the 
laboratory is aimed at using these  
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Figure 21 - Adipose tissue-specific MAP4K4 knockdown results in increased adipogenic gene 
expression.  
 
Preadipocytes from subcutaneous adipose tissue of pSicoT-MAP4K4 (shM4K4) and pSicoT-MAP4K4/aP2-
Cre (shM4K4/aP2-Cre) mice were isolated and differentiated into mature adipocytes. MAP4K4, GLUT4, aP2, 
and CEBPα levels were determined in these adipocytes by RT-PCR. Experiments were performed with cells 
from 3 to 6 different mice in each group. mRNA levels are expressed +/- s.e.m. *p<0.05. 
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mice to explore the physiological relevance of adipose tissue MAP4K4 depletion 
to whole body metabolic regulation. 
 
Discussion 
   This study reports two key results. First, we report the successful application 
and standardization of a lentiviral-based shRNA delivery system for silencing 
genes in 3T3-L1 adipocytes. Secondly, we provide evidence to support the 
usefulness of this shRNA delivery system in creating transgenic mice showing 
gene silencing in an adipose tissue-specific manner. During the course of our 
studies in applying and standardizing this lentiviral-based shRNA delivery system 
a manuscript from another group reported findings very similar to ours [94]. 
Nonetheless, following manipulation of the lentiviral vector we were able to 
extend our studies by developing a method for achieving adipose-specific gene 
silencing in mice. Even though others have demonstrated global or tissue-
specific shRNA-mediated gene silencing in other tissues in mice [66, 91], to my 
knowledge we are the first to achieve adipose-specific gene silencing in mice.  
    The lentiviral vectors used in this study are replication-defective retroviral 
vectors from the lentivirus human immunodeficiency virus (HIV). In addition to 
structural gag, pol, and env genes common to retroviruses, HIV and other related 
lentiviruses contain two regulatory genes, tat and rev, essential for viral 
replication, and four accessory genes, vif, vpr, vpu, and nef, that are vital for in 
vivo replication and pathogenesis [95]. However, to enable the safe use of 
lentiviral vectors as biological tools, these vectors have been significantly 
modified to incorporate numerous safety features. For instance, the lentiviral 
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genetic elements have been split onto 4 different plasmids, i.e. a packaging 
plasmid containing gag and pol coding sequences, a second packaging plasmid 
containing rev coding sequence, a third packaging plasmid containing G 
envelope glycoprotein of vesicular stomatitis virus (VSV G) coding elements, and 
the backbone lentiviral plasmid (any transgenes of interest and cis-acting 
elements of HIV). Furthermore, numerous viral genes necessary for in vivo 
replication have been removed and modifications in the 3I long terminal repeat 
(LTR) of the lentiviral backbone plasmid were made to allow these vectors to be 
inactivated (inability to replicate) once infection took place [91, 95].  
   The best conditions for achieving gene silencing may differ from cell type to cell 
type. During our studies in 3T3-L1 adipocytes we determined that under the 
same conditions, an MOI of 6 (based on GFP expression) was sufficient to 
achieve almost 100% transduction efficiency, whereas an MOI of 0.5 was 
sufficient to achieve the same result in 293FT cells. One reason for this could be 
that 293FT cells have a much higher expression of lentiviral receptors (CD4, 
CXCR4 and CCR5), compared to 3T3-L1 adipocytes, thus requiring a higher 
lentiviral titer. This idea is supported by expression profile data from the Novartis 
GNF Symatlas bioinformatics databases [96]. Furthermore, even though an MOI 
of 6 was sufficient to achieve almost 100% transduction efficiency in 3T3-L1 
adipocytes, an MOI of 72 was necessary for significant gene knockdown. The 
reason for this may be due to the different strengths of the cytomegalovirus 
(CMV) and U6 promoters in driving GFP and shRNA expression respectively, as 
is suggested in studies by Zhou et al [97]. Nonetheless, at a lentiviral MOI of 72 
we did not observe any evidence of toxicity in 3T3-L1 adipocytes, but we did 
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observe decreases in total protein at an MOI of 144. This could have been due to 
high lentiviral titers or shRNA off target silencing. Further studies may be 
required to explore this.    
   Once the conditions have been standardized, the method of using lentiviral 
vectors to deliver shRNAs to 3T3-L1 adipocytes offers a number of advantages 
over commonly used siRNA transfection methods such as electroporation, and 
other viral-based shRNA delivery methods. Electroporation is the most commonly 
used method to introduce siRNAs into 3T3-L1 adipocytes. During this event 
adipocytes are subjected to cellular stress and there may be extensive cell death. 
Retrovirus and adenovirus-based methods have been employed as exogenous 
gene delivery for other cell types [reviewed in 98]. Whereas gammaretroviruses 
such as the murine leukemia virus (MLV) have been used successfully in 
delivering exogenous genes and shRNA to 3T3-L1 fibroblasts, these viruses 
cannot transduce non-dividing cells including 3T3-L1 adipocytes. The reason for 
this is that their viral capsids are too large to pass through the nuclear pore of 
non-dividing cells whereas that of lentiviruses is not. Thus, these retroviruses 
may only infect cells actively undergoing cell division [reviewed in 98]. Adenoviral 
vectors on the other hand have been used successfully to transduce 3T3-L1 
adipocytes [99]. In comparison to lentiviral vectors some demerits of adenoviral 
approaches are that transduction efficiencies are relatively low and the 
expression of transgenes or shRNAs is transient [99]. With these in mind we 
believe this lentivirus-based method offers an efficient shRNA-delivery system for 
mature 3T3-L1 adipocytes.   
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   We sought to extend our study further beyond more efficient gene silencing in 
3T3-L1 adipocytes, to develop a means of achieving adipose-specific gene 
silencing in mice. Work by Ventura et al suggested the pSico lentiviral vector 
could be used to achieve tissue-specific gene silencing, when used with Cre 
recombinase [66]. To achieve this infectious lentiviral particles are microinjected 
directly into the perivitelline space of fertilized mouse embryos [91]. At the two-
cell stage, microinjected embryos are implanted into the oviduct of 
pseudopregnant mice, and pups from this procedure are genotyped for pSico. 
Whereas this procedure seems straightforward our inexperience with the 
procedures and conditions required for successful transduction of fertilized 
embryos made this approach very challenging. As a result of this we decided to 
manipulate the pSico-Myo1c and pSico-MAP4K4 vectors to enable us to use 
them as DNA vectors for pronuclear injections of fertilized embryos instead. We 
recognized that most of the elements on the pSico plasmid were essential for 
proper lentiviral particle formation and activity so we excised and purified the 
region of the plasmid that coded for the U6-loxP-CMV-EGFP-loxP-shRNA-WRE 
regions. This modified linearized plasmid (pSicoT) was microinjected into the 
pronucleus of fertilized embryos and the microinjected embryos were implanted 
into the oviduct of pseudopregnant mice. Even though the microinjection of the 
plasmid into the pronucleus of a fertilized ovary is technically challenging, the 
University of Massachusetts Medical School Transgenic Mouse Core Facility has 
extensive experience with this approach. 6 to 8 weeks after pronuclear injection 
of our plasmid, pups were genotyped for the pSicoT transgene.  
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    Even though both lentivirus transduction and pronuclear injection of DNA into 
fertilized embryos can be used to create transgenic mice, there are important 
distinctions. The methodology for pronuclear injection of fertilized mouse 
embryos is standardized, compared to lentivirus transduction, where one must 
manipulate the embryo by removing its zona pellucida in order for infection to 
occur. Interestingly, one study suggests that manipulated embryos used in 
lentiviral transduction experiments were delayed in their development in vitro 
compared to their untreated counterparts, implying that this manipulation may 
affect developmental stages of the embryos [100]. On the other hand, the yield of 
rodents positive for a transgene is relatively higher in lentivirus-transduced 
embryos compared to pronuclear injection of DNA [101]. Despite these 
distinctions, both methods offer numerous advantages over the traditional 
method of creating tissue-specific knockout mice. For instance, compared with 
the traditional gene targeting method, the RNAi method is quicker and less 
challenging. Whereas it may take at least 18 to 24 months to generate a tissue-
specific knockout mouse using conventional homologous recombination 
approaches, the method we describe here may take 5 months, from ordering 
shRNA oligonucleotides to obtaining the first conditional knock down mice. Also, 
RNAi acts dominantly so only one allele of transgene is needed to suppress the 
endogenous target gene [102], precluding the need to breed two mutant alleles 
and thus reducing time. Furthermore, whereas RNAi-mediated gene silencing 
does not offer complete ablation of the target gene, it does provide one the ability 
to explore the role of certain genes that may result in early embryonic or post-
natal lethality. It is also important to consider drawbacks to the RNAi-mediated 
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gene silencing approach. One concern in RNAi-dependent experiments is the 
issue of non-specific effects, and this may be an even bigger concern with in vivo 
experiments. In our studies we tried to minimize the possibility of this by blasting 
shRNA sequences in GenBank to determine if our chosen shRNA sequences 
targeted any other mouse genes. Another limitation to our described approach is 
that insertion of the transgene in the mouse genome is random. This is 
particularly an issue because shRNA expression is susceptible to position-effect 
variegation, i.e. inactivation as a result of juxtaposition with heterochromatin 
[103]. This limitation was an issue for us, especially in our efforts to apply this 
technology to the creation of RNAi-mediated Myo1c knockdown mice. One way 
to overcome this is by targeting the transgene to a site that allows ubiquitous 
expression of exogenous genes, such as Rosa-26 locus [107].  
   Despite our success in employing this technology to silence MAP4K4 in an 
adipose-specific manner, we encountered a puzzling situation in which we were 
unable to silence Myo1c expression, despite performing the same experiments 
under very similar conditions. As summarized in Table 1, we obtained 6 founder 
mice from our pronuclear injection of pSicoT-Myo1c plasmid. Of these 6 mice, 
only 2 mice passed on the pSicoT-Myo1c transgene to its offspring, despite 
numerous rounds of crosses. This observation suggests that the transgene was 
present in the germ line of only 2 out of 6 mice and highlights the issue of 
mosaicism, where the transgene may not be present in every cell because of the 
timing of fertilization and microinjection of the one-cell embryo with the 
transgene. Nonetheless from crosses of these mice with aP2-Cre mice we were 
able to successfully obtain transgenic mice that were positive for pSicoT-Myo1c 
 91 
and aP2-Cre recombinase. As shown in Figure 16 and demonstrated in Figure 
15a Cre recombinase activity should result in pSicoT-Myo1c excision, shRNA 
induction and Myo1c silencing. We observed pSicoT-Myo1c excision in adipose 
tissue depots, suggesting Cre recombinase was active. However we also 
observed pSicoT-Myo1c excision in muscle tissue, suggesting the Cre 
recombinase activity in this line of mice was not specific (Figure 17b). This was 
not the case with all aP2-Cre mice used since the pSicoT-MAP4K4 mice showed 
adipose specific activity (Figures 18b and 18c). In spite of Cre recombinase 
activity in pSicoT-Myo1c mice however, we did not see any evidence of Myo1c 
knockdown in any tissue tested, or in either of the pSicoT-Myo1c transgenic 
mouse lines (Figure 17c). Whereas this result is puzzling at first, it highlights the 
strong possibility that the truncated pSicoT-Myo1c transgene was inactivated as 
a result of its site of integration in both lines of mice tested. It has been reported 
by others that juxtaposition of shRNA coding elements with heterochromatin 
results in a silencing effect of shRNA expression [103], and we strongly suspect 
this was the case for us since we did not observe any shRNA expression in 
tissues from the pSicoT-Myo1c mice.  On the other hand, our demonstration of 
adipose-specific knockdown of MAP4K4 in pSicoT-MAP4K4/aP2-Cre mice is a 
testament that our plasmid-based technology provides an economical and rapid 
means of creating transgenic mice with specific genes knocked down in adipose 
tissue. For us, these mice set the stage for characterization of the role of 
MAP4K4 in glucose metabolism in vivo, and our preliminary results suggest an 
interesting correlation to data we obtained from experiments in cultured 
adipocytes.  
 92 
    Finally, with the availability of mice expressing Cre recombinase under a 
variety of tissue-specific promoters, we foresee endless opportunities to explore 
the role of specific genes in specific tissues using this technology. However, 
when using this method one must be aware of the potential pitfalls that our 
approach presents and thus adopt the necessary methods to overcome or 
minimize them. Nonetheless, under the right conditions we envision this 
technology as an excellent means of deriving quick and reliable information on 
the importance of a particular gene in vivo.  
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Chapter IV 
     Discussion of Perspectives 
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   With the discovery of GLUT4 almost 20 years ago, and the subsequent 
identification of numerous regulators of insulin-dependent glucose uptake there 
are still many questions that remain unanswered. Transgenic mouse studies 
have significantly assisted our understanding of how these regulators function 
within an in vivo context, but there are numerous proteins whose roles are yet to 
be defined in vivo. One of our objectives was to characterize the role of Myo1c 
during glucose uptake, by exploring its mechanism of action. In both muscle and 
adipose cells there is good evidence that the actin cytoskeleton is an important 
regulator of the GLUT4 trafficking pathway. In adipocytes we suspect one major 
facilitator of actin-dependent GLUT4 trafficking is the unconventional myosin 
Myo1c. Work to date suggests Myo1c plays a unique role in potentiating glucose 
uptake by mediating key events at the adipocyte periphery. We believe that 
Myo1c could be functioning in at least two different mechanisms to facilitate 
GLUT4 trafficking events. For instance based on data from our laboratory [48] 
and Yip et al. [108], Myo1c may regulate GLUT4 trafficking events by facilitating 
GLUT4 vesicle transport to the cell periphery. However, based on data from this 
study and others [49, 46] an emerging hypothesis suggests Myo1c functions to 
potentiate GLUT4 fusion by anchoring to PIP2-rich plasma membrane patches 
and facilitating cortical actin remodeling events, which creates an environment 
whereby signaling molecules, GLUT4-containing vesicles, and SNARE proteins 
interact to promote the insertion of GLUT4 into selective regions in the plasma 
membrane. This is illustrated in Figure 22. Our observation that GLUT4 
accumulates in Myo1c-induced membrane ruffles prior to fusion with the plasma 
membrane [46] functionally ties Myo1c to the GLUT4 fusion event.  
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Figure 22 - Hypothetical model for how Myo1c in association with Rictor may be regulating 
cortical actin dynamics and facilitating GLUT4 vesicle fusion events. 
1. Myo1c anchors to PIP2-rich regions of the plasma membrane and binds cortical actin. Rictor 
association with Myo1c occurs within the head domain, and facilitates cortical actin dynamics by 
potentially activating Rho family GTPases (Rho, Rac) and thus actin polymerization through insulin
action. 
2. The newly polymerized actin serves as more substrate for Myo1c ATPase activity, resulting in 
further cortical actin dynamics. Cortical actin remodeling, or membrane ruffling provides mechanical
force, which facilitates interaction between v-SNARES on GLUT4 vesicles and t-SNARES on the
plasma membrane, and promotes GLUT4 vesicle fusion with the plasma membrane.  
 
 
  
 
Insulin
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From these observations it seems cortical actin remodeling concentrates GLUT4 
vesicles in specific locations near the adipocyte periphery and may even promote 
interaction of t- and v-SNARES, thus potentiating the fusion process. Further 
studies are required to explore this idea. Ourselves [35] and others [34] have 
applied TIRF microscopy to gain insights into events that occur during GLUT4 
membrane trafficking and this technique could be useful in exploring our 
hypothesis and gaining further insight into the molecular events of GLUT4 
trafficking that are regulated by Myo1c. 
   One important insight into the mechanism by which Myo1c functions to regulate 
cortical actin remodeling in adipocytes comes from our identification of Rictor as 
a binding partner of Myo1c. Whereas the findings we report in Chapter II do not 
directly explain how Myo1c functions to promote GLUT4 fusion events, they offer 
numerous hypotheses as to how Myo1c activity may be regulated. For instance, 
through association with Myo1c's head domain Rictor may regulate Myo1c's 
ATPase and motor activities. At this moment there are no studies on the 
contribution of Myo1c's ATPase and motor activities to GLUT4 trafficking events 
so this could be an interesting area for further research. Rho family GTPases are 
known modulators of cortical actin remodeling in numerous cells [reviewed in 84] 
including adipocytes [109]. Rictor is known to activate Rho family GTPases  
[reviewed in 68] so another possibility is that Rictor and Myo1c could be part of 
machinery that leads to the activation of these proteins (Figure 22). Further work 
will be required to explore this idea.  
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   As discussed in Chapter I, Akt activation and cortical actin remodeling are 
important events necessary for GLUT4 translocation and an interesting possibility 
that is raised by our identification of the novel Rictor-Myo1c complex is that 
Rictor may be a central element in GLUT4 trafficking by virtue of its dual role in 
controlling upstream modulators of GLUT4 translocation, i.e. the insulin signaling 
pathway that activates Akt via a Rictor-mTOR complex, and the actin 
polymerization pathway leading to membrane ruffling, via a Rictor-Myo1c 
complex. Even though our GLUT4 translocation and 2-Deoxyglucose uptake 
assays in Chapter II provide evidence of Rictor's general importance to GLUT4 
translocation and glucose uptake, we do not have sufficient data to be able to 
compare the individual contributions of the Rictor-mTOR complex and the Rictor-
Myo1c complex to GLUT4 trafficking. Further work will be required to explore this 
idea.   
   Another objective of our initial studies was to understanding the physiological 
relevance of Myo1c in vivo. Whole body Myo1c knockout mice show 
developmental haploinsufficiency and embryonic lethality [110] so we focused 
our efforts on creating adipose-specific Myo1c knockout mice to explore this 
question. Our first attempt involved a conditional knockout strategy where a 
transgenic mouse expressing a Myo1c allele with loxP sites in two introns of the 
gene would be made, and then crossed with another transgenic mouse 
expressing Cre Recombinase in an adipose-specific manner. Despite successful 
construction of a Myo1c targeting vector with loxP sites flanking the third Myo1c 
exon, we were unable to identify embryonic stem cells that had successfully 
taken up the targeting vector through homologous recombination, even after 
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screening over 600 ES cells. Reports from at least 3 different laboratories 
proposed an innovative approach to creating mice deficient in a specific gene by 
combining RNAi and gene transfer via lentivirus [65, 66, 90] so we decided to 
apply this approach. This lentivirus-mediated RNAi approach was also attractive 
to us because it offered a means of optimizing siRNA delivery and achieving 
stable RNAi in 3T3-L1 adipocytes. In Chapter III we report the successful 
application of the lentivirus-mediated RNAi approach to gene silencing in cultured 
adipocytes, with results very similar to that of Liao et al [94]. In our studies we 
found that our shRNA-expressing lentivirus infected adipocytes with high 
efficiency and for Myo1c at least, it resulted in greater silencing of gene 
expression than had been previously seen with siRNA oligos. It was important for 
us to characterize this approach for use in cultured adipocytes to ensure that 
lentivirus infection did not disrupt insulin signaling or normal adipocyte biology, 
especially as we sought to apply this technique to other questions [88]. Chapter 
III describes our efforts in developing lentivirus-mediated technology for gene 
silencing purposes in cultured adipocytes but it is important to note that the 
conditions we describe here will also enable the successful application of this 
technique to exogenous gene expression in cultured adipocytes [89]. One 
drawback to this approach is that even though lentiviral vectors have been 
significantly manipulated to ensure safety they still remain dangerous and 
production requires a special laboratory environment (Biosafety Level 3). As such 
it may not be possible to work with lentiviruses in some laboratories. However if 
the goal is to achieve long-term gene silencing or exogenous gene expression in 
cultured adipocytes the lentiviral-delivery remains a good approach.  
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   Our ultimate goal for the lentivirus-mediated shRNA delivery system was to 
create transgenic mice that had reduced levels of a protein of our interest 
specifically in adipose tissue. We chose Myo1c and MAP4K4 for this project. 
Despite successful development of infectious virus that silenced Myo1c and 
MAP4K4 in 3T3-L1 adipocytes, the greatest challenge we faced during this 
endeavor was delivering infectious lentiviral particles to mouse embryos. With the 
assistance of the UMass transgenic core facility we attempted to inject infectious 
lentivirus into the perivitelline space of fertilized mouse embryos, but were unable 
to obtain any founders from this approach, despite screening over 100 mice. This 
is probably not due to problems with the viral particles since all viral solutions 
were tested for infectivity in 293FT cells prior to mouse embryo injection. In light 
of this setback we decided to modify the lentiviral vectors by removing 
exogenous viral elements such that it could be used for mouse embryo 
pronuclear injection. This approach gave us some founders but adipose-specific 
gene silencing was only achieved in the case of MAP4K4. There is no doubt that 
the approach we describe to creating conditional mice in Chapter III presents 
challenges but with the right precautions and controls we believe this method 
offers substantial advantages over traditional approaches. However, if this 
method is to be used, future work will have to focus on developing ways to direct 
the pSicoT transgene to sites within the genome that do not interfere with normal 
biological processes, and away from sites that may result in silencing of the 
transgene. Already there are reports of ways this can be achieved [103]. This 
should overcome possibilities for variable transgene expression and enable 
ubiquitous expression of the pSicoT transgene in vivo. 
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   There are numerous mechanisms through which the insulin signaling pathway 
can be disrupted, but one major means is through the inhibitory phosphorylation 
of IRS-1 serine residues (Ser307 and Ser632 in the mouse IRS-1, and Ser636 
and Ser1101 in humans) [reviewed in 104]. This prevents IRS-1 interaction with 
the insulin receptor, and abrogates signaling events downstream of IRS-1. TNF-α 
and free fatty acids have been found to induce insulin resistance at least in part 
through inhibitory IRS-1 serine phosphorylation, but it should be noted that there 
have also been reports of instances in which IRS-1 serine phosphorylation 
positively activates insulin signaling [reviewed in 105]. Nonetheless, the TNF-α 
and free fatty acid-induced pathways leading to insulin resistance are believed to 
involve the serine kinases IKK and JNK, which are major components of 
proinflammatory pathways. As discussed in Chapter I, insulin-resistant states 
including obesity and Type 2 Diabetes are also associated with increased 
activation of JNK and/or IKK in parallel with inhibitory serine phosphorylation of 
IRS-1, and this could be a potential link between obesity, inflammation, and 
negative regulation of insulin action [105]. We believe MAP4K4 could be an 
important element in this link. In cell systems other than adipocytes it has been 
proposed that MAP4K4 may be acting as an activator of JNK1 [reviewed in 106] 
but studies from our laboratory suggest MAP4K4 depletion in 3T3-L1 adipocytes 
has no effect on the ability of TNF-α to induce JNK1 phosphorylation [26]. 
However, following TNF-α treatment of 3T3-L1 adipocytes we observed robust 
JNK1/2 and p38 SAP kinase phosphorylation, activation of the transcription 
factors c-Jun and ATF2, and a significant increase in MAP4K4 expression [25]. 
These observations suggest MAP4K4 may be part of an intricate TNF-α pathway, 
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which acts to downregulate GLUT4 expression and adipogenesis. We envision 
the adipose-specific MAP4K4 knockdown mice will be an excellent model for us 
to test our hypotheses. As discussed earlier, data from experiments in cultured 
adipocytes also present a hypothesis in which MAP4K4 acts as a negative 
regulator of adipogenesis by suppressing PPARγ expression and triglyceride 
synthesis. By knocking down MAP4K4 in 3T3-L1 adipocytes, the block on 
PPARγ expression is removed and there is an increase in fatty acid storage as 
triglycerides [26], and potentially larger adipocytes. Our preliminary observations 
of adipose tissue from MAP4K4 knockdown mice suggest all fat depots had a 
greater mass in comparison to littermate controls (data not shown). Our 
continuing studies are focused on exploring whether this is due to more 
adipocytes within the tissues or larger adipocytes. During these studies we will 
also seek to determine whether there is an increase in triglyceride content in 
adipocytes from MAP4K4 knockdown mice, compared to control mice. Since we 
are also interested in exploring the role of MAP4K4 during insulin resistance, 
future studies with these mice will involve High Fat Diet and total body weight 
gain studies, fat pad and liver weight analysis, as well as an analysis of adipocyte 
size. MAP4K4 has been shown to act as a negative regulator of 2-deoxyglucose 
uptake in 3T3-L1 adipocytes so future studies will also entail glucose and Insulin 
tolerance tests of adipose-specific MAP4K4 knockdown mice, compared to 
control littermates, as well as glucose transport and insulin signaling experiments 
on adipocytes from these mice.  
   Another area of interest for us is MAP4K4's potential role in macrophage 
inflammation through TNF-α signaling. Apart from adipose tissue, there is also 
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evidence of aP2 promoter activity in macrophages so there is a good possibility 
that MAP4K4 protein levels may be decreased in macrophages of our MAP4K4 
knockdown mice. We will examine macrophages from these mice to determine 
the extent, if any, of MAP4K4 depletion. The MAP4K4 knockdown mice could 
thus offer an excellent means for us to explore the role of MAP4K4 in 
macrophage inflammation in vivo. For instance to test whether MAP4K4 plays a 
role in TNF-α expression and macrophage inflammatory response, MAP4K4 
knockdown mice could be injected with Lipopolysaccharide (LPS) to activate 
production of cytokines including TNF-α, which acts as an endogenous 
inflammatory mediator. A measure of TNF-α levels in macrophages and serum 
from MAP4K4 knockdown mice, compared to control mice would give a good 
indication of whether MAP4K4 played a role in TNF-α expression in 
macrophages. Furthermore, an examination of JNK1/2, p38 and ERK1/2 
phosphorylation levels in macrophages from MAP4K4 mice following LPS 
injection could provide information on whether the proinflammatory pathway 
defined by MAP4K4 involves the JNK1/2, p38, ERK1/2 and NFκB pathways. This 
is particularly important because it is becoming increasingly apparent that 
macrophages not only play an immense role in inflammatory amplification in 
obesity, but also contribute to insulin resistance through TNF-α and other 
inflammatory cytokine production.  
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Reagent Repository 
 
 
 
 
Reagent Location in Czech lab Box ID 
Rabbit anti-Myo1c polyclonal antibody Freezer B (-20oC) second shelf Myo1c antibodies 
3xHA-Myo1c full length 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
3xHA-Myo1c (motor + IQ)  
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
3xHA-Myo1c (IQ + Tail) 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
3xHA-Myo1c (Tail) 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
GFP-Myo1c 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSico empty lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSicoR empty lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSico Myo1c shRNA 3 lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSico MAP4K4 shRNA 1 lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSicoR scrambled shRNA lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSicoR Myo1c shRNA 1 lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSicoR Myo1c shRNA 2 lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSicoR Myo1c shRNA 3 lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSicoR Myo1c shRNA 6 lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSicoR MAP4K4 shRNA 1 lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSicoR MAP4K4 shRNA 2 lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
pSicoR MAP4K4 shRNA 3 lentiviral vector 
 
Freezer D (-80 oC) top shelf Nana glycerol stocks 
